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Abstract
AGE-RELATED GENETIC AND EPIGENETIC CHROMOSOMAL CHANGES: A
TWIN STUDY
Kimberly Haydu Jones, B.S.

A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2009

Director: Colleen Jackson-Cook, Ph.D.
Department of Pathology
The primary aims of this study were to examine acquired genetic and epigenetic
changes that occur in individuals with increasing age and to determine how these changes
are influenced by genetic/environmental factors. Acquired genetic changes were
assessed by determining the frequency and chromosomal contents of spontaneously
occurring micronuclei in identical and fraternal twins. A total of 115 individuals (48 twin
pairs and 19 singletons) were evaluated, ranging in age from 7 to 85 years. As expected,
micronuclei frequencies, which are indicative of genomic damage, significantly increased
with age (p<0.0001, r=0.446). The majority of micronuclei (32%) contained sex
chromosomes and the frequency of sex chromosome-bearing micronuclei significantly
increased with age (p<0.0001). The frequency of autosome-containing micronuclei was
not significantly influenced by age or gender. However, some autosomes were seen more
(chromosomes 4, 8, and 9) or less (chromosomes 17 and 22) frequently than expected by
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chance (p<0.05). An evaluation of the numerical contents of the sex chromosomecontaining micronuclei and their corresponding binucleates showed that the majority of
the binucleates had an abnormal chromosomal complement (either hypodiploid or
hyperdiploid), with the subset of binucleates having a normal chromosomal complement
decreasing with age for both the Y chromosome in males and the X chromosome in
females. Model fitting, implemented in Mx, showed the variation in the frequency of
micronuclei to be best explained by either additive genetic and unique environmental
components, or common and unique environmental factors. Specific environmental
exposures and health conditions that were shown to influence micronuclei frequencies,
included: multivitamins, leafy green vegetables, fruit, vitamin E supplements, arthritis,
heart disease, allergies, and alcohol.
To assess acquired epigenetic changes, global methylation profiles of two identical
twin pairs were compared and found to differ, indicating that individuals do develop
alterations in their methylation profiles with age. Furthermore, the twin pair having a
significant difference in their micronuclei frequencies and environmental exposures had
more differences in their methylation pattern compared to the twin pair whose
micronuclei frequencies and environmental factors did not differ. Overall, genetic and
epigenetic changes were shown to occur with age and to be influenced by genetic and
lifestyle factors.

Chapter 1.

Background and Significance

It has long been known that constitutional chromosomal abnormalities can have a
dramatic effect on an individual’s health. Although acquired chromosomal anomalies
have been associated with many disease states, such as cancer, little is known about their
etiology. In addition to cancer, new evidence is rapidly accumulating to suggest that
there may also be a link between acquired chromosomal changes and other age-related
disease states, such as Alzheimer’s disease (Zekanowski and Wojda 2009), rheumatoid
arthritis (Tascioglu et al., 2005), and osteoarthritis (Castellanos et al. 2004, Dahlen et al.,
2001, Kinne et al., 2001, Mertens et al., 1996, Broberg et al., 1998). Before the
significance of this relationship can be understood, more information needs to be
gathered regarding which specific chromosomal changes occur with age and how these
changes vary in the normal population.
The idea that an individual may acquire chromosomal abnormalities with age was
first proposed in 1961 by Jacobs et al., who first discovered an increase in somatic cell
chromosome loss with age. Since then, research studies have led to the conclusion that
sex chromosomes are most often involved in acquired aneuploidy and that an age effect
exists, with sex chromosomes being lost with increasing age (Fitzgerald and McEwan,
1977; Hando et al., 1994; Mukherjee et al., 1995). Interestingly, this age-related loss of
sex chromosomes has been noted to be most pronounced in females (Fitzgerald and
McEwan, 1977; Wojda and Witt, 2003).
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Much less information is available regarding the frequency of autosomal
abnormalities that are acquired with age, with the existing data leading to conflicting
conclusions (Mukherjee et al., 1997; Hando et al., 1994). The results of the few studies
that have directly evaluated specific autosomal involvment in acquired aneuploidy
frequencies (using fluorescence in situ hybridization (FISH) techniques on interphase
cells) have supported the premise of a non-random pattern of autosomal loss. The nonrandom trend of autosomal involvement seems to favor the loss of chromosomes with
large blocks of heterochromatin (Stacey et al., 1995; Mukherjee et al., 1996; Fauth and
Zankl 1999; Leach et al., 2004), which may provide valuable insight into the mechanism
of chromosome loss.
An alternative method for studying acquired chromosomal changes is through use
of the cytokinesis-blocked micronucleus (CBMN) assay. Micronuclei are small round
bodies, containing whole chromosomes or chromosome fragments left behind during
anaphase and thus not included into the daughter nuclei (Figure 1). The frequency of
micronuclei serves as an indication of DNA damage having been shown to provide
estimates of chromosomal abnormalities that are comparable to those quantified using
traditional metaphase analysis for detecting genomic instability (Miller et al., 1998;
Bonassi et al., 2001). Similar to the results of FISH studies on interphase cells, much of
the information collected regarding micronuclei, to date, has shown that the majority of
micronuclei contain sex chromosomes (Guttenbach et al., 1994; Hando et al., 1994;
Richard et al., 1994; Zijno et al., 1996; Catalan et al., 1995 and 1998; Norppa and Falck,
2003). Furthermore, these frequencies have been shown to increase with age (Bolognesi

2

mn

binucleate

Figure 1. The appearance of a Giemsa stained micronucleus (mn) and corresponding
binucleate from a lymphocyte culture.
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et al., 1999; Bonassi et al., 2001), with the most dramatic increase in micronuclei being
apparent between the ages of 50 and 69, followed by a decrease in micronuclei in
individuals who live beyond age 69 (Wojda and Witt 2003; Bolognesi et al., 1997).
Micronuclei frequencies have been shown to be higher in females, but this observation
has not been consistently seen in all studies (Bonassi et al., 2001).
While numerous studies have been completed for adults, there is a paucity of
information available about micronuclei frequency rates in children. Meta- and pooled
analyses have been performed to estimate a baseline level of micronuclei frequencies in
children with no observable gender effect (Neri et al., 2005). The small amount of
current information regarding acquired autosomal abnormality frequencies in children
also suggests a non-random pattern of chromosome involvement in micronuclei (Fauth et
al., 1998; Norppa and Falck, 2003). However, researchers have reported mixed results as
to which autosomes are excluded into micronuclei most frequently and whether or not
there is an increase in autosome-containing micronuclei with age. Among the autosomes
that have been suggested to show an over-representation in micronuclei in children are
chromosomes 1, 9, and 16, which are chromosomes that have large blocks of
heterochromatin (Sawyer et al. 1995; Stacey et al. 1995; Norppa and Falck, 2003).
In addition to studies of acquired numerical abnormalities, investigators have also
evaluated the frequency of acquired structural changes that are present in micronuclei.
Although the majority of micronuclei in normal, aged individuals contain what appear to
be intact, structurally normal chromosomes (Wojda and Witt, 2003), this observation has
not been consistently observed in the micronuclei seen in people having various health
conditions. In Parkinson’s disease and systemic lupus erythmatosus, there is an increase
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in micronuclei containing acentric fragments, yet Alzheimer’s disease patients have been
shown to have an increase in micronuclei containing whole chromosomes (Migliore et
al., 1997; 1999a; 1999b). Although there have been some studies regarding the
frequencies of micronuclei, information regarding the chromosome-specific contents and
structure is far from complete.
Several investigators have reported an increase in micronuclei frequencies in
patients having cancer when compared to healthy individuals (Tucker and Preston, 1996;
Duffaud et al., 1997; Venkatachalam et al., 1999; Znoar et al., 2003; Olaharski et al.,
2006; Bonassi et al., 2007). Micronuclei frequencies have also been found to be
increased in patients with Alzheimer’s and Parkinson’s disease (Migliore et al., 1997;
Migliore et al., 2002). The cause of this increase in peripheral blood micronuclei
frequencies remains controversial, and seems to vary with the specific disease. For
example, the increase seen in Parkinson’s patients has been speculated to arise from the
“endogenously produced or exogenous toxins capable of damaging, via oxidative
mechanisms, nigral dopaminergic neurons as their principal target” (Migliore et al.,
2002). Alternatively, the increased frequency of micronuclei in Alzheimer’s patients has
been linked to a defect in microtubule assembly (Migliore et al., 1997). In cancer, one
theory is that the correlation of lymphocyte micronuclei frequencies reflects genomic
damage that also contributes to cancer initiating events in other tissues (Bonassi et al.,
2007).
Some researchers have reported that environmental factors influence the
frequency of acquired chromosomal abnormalities. The factors that have been shown to
influence micronuclei frequencies include diet, hormone supplementation, and tobacco
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usage, with the association of tobacco usage and micronuclei frequencies varying from
no effect to increased frequencies (reviewed in Battershill et al., 2008; Fenech 1993;
Schneider et al., 2001; Bonassi et al., 2001).
Differences in micronuclei frequencies observed between individuals have also
been reported, with genetic influences being postulated to impact the frequency of
acquired chromosomal abnormalities. Of particular interest are the results of a study
reported by Bonassi and Fenech (2004), who found that chronic in vitro alcohol treatment
induced an increase in micronuclei frequencies in cell lines having a BRCA1 gene
mutation. Researchers have also consistently found an increased frequency of
micronuclei with alcohol use in individuals having genetic variants in the alcohol
metabolizing enzyme, alcohol dehydrogenase (Ishikawa et al., 2006; Kim et al., 2005).
The exact role genetics and/or environment play in acquired chromosomal abnormalities
is still largely unknown.
Twin studies are a useful way to determine the role that environment and genetics
play in determining observed phenotypic variations. Phenotypic differences in
monozygotic twins are usually treated as evidence of an environmental influence. To
date, very few studies have examined the frequency of acquired chromosomal
abnormalities in twins. One such study, by Jarvik and Kato (1970), found a genetic
contribution to aneuploidy in 61 adult twins studied. However, this investigation was
performed using metaphase cells, prior to the advent of chromosome banding technology.
Thus, the completion of a twin study analyzing the role of genetics and/or environment
on acquired chromosomal abnormalities, using today’s technology, is long overdue.
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While acquired chromosomal changes in DNA (aneuploidy) have been noted for
almost 50 years, it was only recently recognized that chromatin has the potential to
undergo epigenetic changes with advancing age. Epigenetic modifications, such as DNA
methylation, play an important role in the control of gene expression and chromosome
structure (Frigola et al. 2002; Peaston and Whitelaw, 2006). Simplistically, methylation
typically prevents gene expression, while loss of methylation allows transcription. Some
researchers report that methylation increases with age, while others report an overall
decrease in methylation with age (Golbus et al., 1990; Cooney, 1993; Vertino et al.,
1994; Toyota et al., 1999; Geigl et al., 2004; Clayton et al., 2005; Wojdacz and Hansen,
2006). The cause of these changes in methylation patterns with age is unknown. Some
believe it is a function of diet and environment, while others believe it to be a random
process (Cooney, 1993; Fenech 2002; Jaenisch et al., 2003; Bjornsson et al., 2004;
Peaston and Whitelaw, 2006). It has been hypothesized that as humans age, they
accumulate epigenetic and/or chromosomal changes over time (Wong et al, 2005;
Petronis, 2006). Once multiple changes are acquired, they may result in the development
of an age-related complex disease. In fact, many cancer cells have been shown to
develop epigenetic changes (reviewed by Iacobuzio-Donahue, 2009). Some scientists
have argued that epigenetic changes are more clearly associated with tumor progression
than specific mutations (Feinberg and Tycko, 2004). However, the role these changes
play in the genesis of disease has not been fully resolved. The possible randomness and
unpredictable nature of these changes in DNA methylation has been suggested as an
explanation for the observations in monozygotic twins, who have no evident differences
in environmental exposure, being discordant for certain diseases (schizophrenia at 50%
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discordance for MZ twins, 70% for rheumatoid arthritis, and 80% for breast cancer)
(King et al., 1992; Petronis, 2001; Singh et al., 2002). Studies showing no difference in
the frequency of phenotypic discordance between MZ twins raised apart when compared
to MZ twins raised together suggest that this discordance reflects a mechanism other than
environment (Wong et al. 2005). Large amounts of epigenetic changes can accumulate
over thousands of mitotic divisions in cells from two genetically identical individuals
(Petronis 2001). In their paradigm shifting study, Fraga et al. (2005) found that patterns
of epigenetic modifications in monozygotic twin pairs diverge as they become older,
which has been described as epigenetic drift (Martin, 2005). These alterations in an
individual’s epigenetic profile appear to be much more prevalent than DNA mutations
(Bennett-Baker, 2003). In contrast to the study by Fraga et al. (2005), which examined
global epigenetic changes, studies by Petronis et al. (2003) and Agrelo et al. (2006)
examined local epigenetic changes of single, disease-related genes. In these cases, it was
discovered that epigenetic changes in these gene regions appear to be linked to the
disease state. Increasing numbers of autosomal genes were affected by methylation
changes that occur during aging (Wojdacz and Hansen, 2006). Methylation specific
arrays have also been used to evaluate changes in methylation with age. Using this
technology, specific genes that seem to vary in methylation status with age and gender
have been identified and include activin A receptor type I, interleukin 6, caspase
recruitment domain-containing protein 15, platelet-derived growth factor receptor alpha,
nuclear factor kappa-B subunit 1, and ETS-domain protein (Boks et al., 2009).
Since epigenetic mechanisms play a key role in establishing and maintaining
chromosomal structure, specifically heterochromatin and euchromatin, it is possible that
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epigenetic changes could be an underlying mechanism causing the structural and
numerical chromosomal abnormalities associated with aging. Methylation differences
that occur with age have the potential to contribute to somatic mutations, altering normal
chromosome structure (Singh et al., 2002; Jones and Takai, 2001). Chromosomal
translocations have been found to occur in hypomethylated regions (Richardson 2002).
Fauth et al. (1998) found that treatment with the drug 5-azacytidine, which induces
hypomethylation, increased the frequencies of micronuclei containing the chromosomes
1, 9, and 16, which have large blocks of heterochromatin. They concluded that
undermethylation of heterochromatin may be associated with loss of specific
chromosomes.
Thus, while much has been learned regarding the occurrence of acquired
chromosomal abnormalities that arise in humans, many questions remain. Are
individual’s genetically predetermined to acquire these chromosomal changes or are these
chromosomal changes more strongly affected by an individual’s environment? Are these
changes acquired randomly or do commonalities exist between individuals? The primary
aims of this study were to better characterize the chromosome-specific frequencies of
acquired chromosomal abnormalities as assessed through the CBMN assay, and to
determine the extent to which the variation in the frequency of micronuclei was
determined by genetics and/or environment. A secondary aim was to determine if global
methylation patterns varied between twin pairs and with age. These aims were achieved
by testing the following hypotheses:
1. Micronuclei frequencies increase with age.
2. Micronuclei frequencies are influenced by both genetic and environmental
factors.
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3. There is a nonrandom pattern of chromosomal exclusion into micronuclei,
with this pattern being age-related.
4. Methylation patterns change with increasing age.
5. The acquisition of changes in the pattern of methylation within an
individual are positively correlated with their frequency of micronuclei.
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Chapter 2.

Genetic and environmental factors contributing to spontaneous micronuclei
frequencies in children and adults: A twin study.

Introduction

Acquired chromosomal abnormalities were first reported to occur in human
somatic cells in 1961 (Jacobs et al.). Since that initial discovery, the majority of
investigations of acquired chromosomal changes have centered on their association with
particular types of neoplasia. Sandberg (1990) reported that approximately 85% of the
affected tissues from patients with cancer have acquired chromosomal changes. In
addition to cancer, new evidence is rapidly accumulating to suggest that there may also
be a link between acquired chromosomal changes and other age-related disease states,
such as Alzheimer’s disease (Zekanowski and Wojda 2009), rheumatoid arthritis
(Tascioglu et al., 2005), and osteoarthritis (Castellanos et al. 2004; Dahlen et al., 2001;
Kinne et al., 2001; Mertens et al., 1996; Broberg et al., 1998). However, little is known
about the frequency or types of acquired chromosomal changes that spontaneously arise
in healthy humans, especially in children.
One approach for understanding the etiology of acquired chromosomal changes
has been to delineate their frequency of occurrence and to see if consistent patterns
emerge that might suggest a causative factor(s). The “gold standard” for scoring acquired
chromosomal abnormalities has been the evaluation of metaphase chromosomes. While
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this technique allows for full characterization of all cytogenetic findings present, it is
limited in that it is: (1) labor intensive, thereby reducing the number of observations that
can be collected; and (2) at risk for producing “artifactual” anomalies as a result of the
necessary cell culture, harvesting, and slide making procedures. The cytokinesis-block
micronucleus (CBMN) assay has been used as an alternative approach to estimate the
frequency of acquired chromosomal changes. This CBMN assay provides information
regarding the previous interphase/mitotic division of a somatic cell prior to the presence
of selective pressure on the resultant daughter cells. Given that this assay allows for an
assessment of a large number of cells (1000 or more) and is less labor intensive than
conventional cytogenetic studies to perform, it has potential for use as a high throughput
assay.
A micronucleus is defined as a small structure that is juxtaposed to the main
daughter nuclei following mitosis. Micronuclei are thought to contain chromatin (from
one or more chromosomes) that was not incorporated into the daughter nuclei
(“lagging” or “lost”) following cell division (Fenech and Morley, 1985). Micronuclei
frequencies have been shown to increase with both age and DNA damage, providing
data that closely parallels that of metaphase chromosomal analyses (Miller et al., 1998;
Bonassi et al., 2001). Thus, the assessment of micronuclei frequencies has become a
very attractive biosurveillance tool for quantifying genomic damage associated with
environmental insults and occupational exposures, as well dietary and lifestyle habits
(Battershill et al., 2008). As anticipated from the above noted observations regarding
chromosomal changes and age-related conditions, researchers have also reported
micronuclei frequencies to be increased in individuals with different health conditions,
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such as cancer, Alzheimer’s disease, and Parkinson’s disease (Tucker and Preston,
1996; Duffaud et al., 1997; Venkatachalam et al., 1999; Znoar et al., 2003; Olaharski et
al., 2006; Migliore et al. 1997; Migliore et al. 2002). Given the potential use of this
assay for recognizing individuals who may have an increased risk for developing health
problems, it is important to understand the factors that influence alterations in
micronuclei frequencies. In particular, it is not known if most of the variation observed
for micronuclei frequencies reflects environmental exposures, a predisposition based on
one’s genetic make-up, or an interaction between heritable genetic and environmental
factors.
One of the most robust methods for identifying sources of variation in humans is
to study specific traits in twins. Thus, the primary aim of this study was to measure the
frequency of spontaneously occurring micronuclei in twins of differing ages and to
determine the extent to which the variation in the frequency of micronuclei was
determined by genetics and/or environment.
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Materials and Methods

Sample Ascertainment
A total of 48 twin pairs and 19 singletons, whose co-twin did not complete the
sample collection process, were studied.

The twins were ascertained through the Mid-

Atlantic Twin Registry (MATR). Of the 115 participants, 52 were males and 63 were
females. The only study inclusion criterion was that the twins be of the same gender (to
eliminate confounding effects in data interpretation that might arise from potential gender
differences). After providing their informed consent (VCU IRB protocol #179), the
participants submitted blood samples and a completed health history questionnaire.
Blood samples were collected by the participants’ health care providers. Following their
collection, the samples were shipped to our laboratory via an overnight delivery carrier.

DNA Isolation and Zygosity Determination
Genomic DNA was isolated from whole blood using the Puregene DNA Isolation
Kit (Qiagen). Zygosity was determined using 13 highly polymorphic short tandem repeat
sequences (AmpFlSTR Profiler Plus and Cofiler kits, Applied Biosystems, Foster City,
CA) according to standard procedures. Twins were classified as monozygotic if the
marker data for the co-twins matched at all 13 loci. Co-twins having marker differences
were identified as a dizygotic pair.
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Cell Culture
Lymphocytes were isolated using Histopaque-1077 (Sigma) and lymphocyte
cultures were established according to the protocol of Fenech (1993). Briefly,
cytochalasin B (Sigma, 14930-92-2) was added to the cells 44 hours after culture
initiation at a concentration of 3.0 μg/ml. At 72 hours, binucleate interphase cells were
harvested using standard techniques, which included a 10-minute incubation in hypotonic
solution (0.075 M KCl), and serial fixation (three times using a 3:1 methanol: acetic acid
solution). Slides were made following standard procedures (Leach and Jackson-Cook,
2001).

Micronuclei Analysis
The prepared slides were stained for 4 minutes in a 4% Harleco Giemsa solution.
Micronuclei frequencies were determined by replicate scoring (2 times per slide) of the
number of micronuclei observed per 1000 cytochalasin-B blocked binucleates, following
the criteria established by Fenech et al. (2003). The frequency of micronuclei was
calculated by averaging the values obtained from the 2 replicate scores (2000 total
binucleates counted).

Statistical Analysis
Non-parametric Spearman’s correlation coefficients were calculated for the
association comparisons using either the JMP 8 (Version 8.0.1) or R (Version 2.9.1)
statistical analysis packages. The impact of additive genetic (A), common environmental
(C), and/or unique environmental (E) factors on micronuclei frequencies was evaluated
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using an ACE model fitting approach (Neale and Cardon, 1992) (Figure 2). This
analysis, which was implemented in Mx, allowed for an evaluation of the fit of full
(ACE) and reduced (AE, AC, or CE) models with log-likelihood ratio tests. A univariate
regression analysis, with and without correction for age, was used to assess the effects of
health history, lifestyle, and medication usage on micronuclei frequencies. When
indicated by the univariate analysis, general linear modeling was used to assess the agecorrected variation in micronuclei frequencies seen for other potential predictive factors
(such as alcohol use, calcium or multivitamin consumption). In order to limit type I
errors, an alpha level of p<0.05 was used for all statistical tests.
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Figure 2. Path diagram illustrating the potential sources of variance on acquired
chromosomal abnormalities for MZ and DZ twin pairs, additive genetics (A),
common environmental (C), and unique environmental (E). The MZ additive genetic
correlation is 1. The DZ additive genetic correlation is ½. The common environmental
correlation is equal to 1 for both DZ and MZ twins.
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Results

Sample Distribution
The ages of the study participants ranged from 7 to 85 years, and included 52
male and 63 female participants (Table 1). The average age of the male and female
participants was 47.5 and 41.3, respectively. Of the 48 complete twin pairs collected, 33
were determined to be monozygotic, with 15 being dizygotic. The majority of samples
were submitted from individuals living in the Mid-Atlantic region (Virginia and North
Carolina were most common). However, samples were collected from individuals
residing in locales throughout the United States (including California, Colorado, Florida,
Indiana, Michigan, Missouri, North Dakota, Pennsylvania, South Carolina, Texas,
Tennessee, and Washington).

Micronuclei frequencies
No significant difference in micronuclei frequencies was observed between males
(1.39% ± 0.11% [mean ± standard error]) and females (1.22% ± 0.10%) (p=0.87),
regardless of their age (p=0.254) (Figure 3). As a result, the data from males and females
were pooled for all other statistical comparisons. A significant positive correlation was
detected between micronuclei frequency and age (p<0.0001, r=0.446), as shown in
Figures 3 and 4. Interestingly, the highest frequency of micronuclei was observed for the
twins who were 60 to 69 years of age, with the lowest frequencies being noted for the
twins who were 19 years of age or younger. The variation in micronuclei frequencies
observed for the children (ages 7 to 18) ranged from 0.1% to 2%, with variation in
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Table 1. Sample distribution and micronuclei frequencies by age group

Age
Group

Males

Females

Total

7-9
10-19
20-29
30-39
40-49
50-59
60-69
70-79
80+
Total

4
6
1
7
6
6
11
9
2
52

2
18
5
2
13
6
9
6
2
63

6
24
6
9
19
12
20
15
4
115

MN
Frequency per
1000
binucleates
(mean ± s.e.)
5.6+1.1
7.6+ 0.9
14.2+3.7
12.8+1.4
12.9+1.3
11.3+1.3
22.5+2.5
13.3+1.7
14.3+1.1
13.0 + 0.8
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MZ
pairs

DZ
pairs

Singletons

3
7
2
3
6
2
5
3
2
33

0
5
0
0
1
2
3
4
0
15

0
0
2
3
5
4
4
1
0
19
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Males

Micronuclei frequency

30

Females

25
20
15
10
5
0
7yrs9yrs

10yrs19yrs

20yrs29yrs

30yrs39yrs

40yrs49yrs

50yrs59yrs

60yrs69yrs

70yrs79yrs

80yrs+

Age Group
Figure 3. Mean micronuclei frequency by age decade and gender. The
micronuclei frequency is presented as the number of micronuclei scored per 1000
binucleates + standard error. The micronuclei values for males (black histograms)
and females (grey histograms) are shown.
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Figure 4. Correlation of micronuclei frequency with age. Micronuclei
frequencies (Y axis) are presented as the mean number of micronuclei per
1000 binucleates. The spontaneous frequency of micronuclei, plotted in
relation to the 115 study participants’ age (X axis), showed a significant
positive correlation (r=0.446).
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younger adults (19 to 49) and middle-aged to older twins (50 or older) ranging from 0.3%
to 3% and, 0.4% to 4.5%, respectively.

Micronuclei frequencies and genetics
The correlation coefficient for micronuclei frequencies between monozygotic
twins (who share all of their genes) was 0.5 (p=0.003) compared to 0.42 (p=0.118) for the
dizygotic twins (who share half of their genes). Given that the correlation between
identical twins was only 0.5, one can infer that there are unique environmental factors
influencing the frequency of micronuclei. However, the ACE model fitting analysis
showed that unique environmental effects alone (E) provided a significantly poor fit to
the data (p<0.0004). While none of the models evaluated showed a strong fit to the data,
the best fitting models were those that included influences from both additive genetic and
unique environment (AE), or both common and unique environmental effects (CE)
(Table 2).

Micronuclei frequencies and health history questionnaire information
Given that unique environmental effects, in conjunction with either additive
genetic and/or common genetic effects, appear to contribute to the observed variation in
micronuclei frequencies, we assessed the effect of various unique environmental and
health components on micronuclei frequencies (Tables 3 and 4). An initial univariate
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Table 2. Mx ACE model fitting.
Model
-2LnL
k
ACE
285.099
4
CE
285.099
3
AE
286.794
3
E
300.657
2
k= parameters
AIC= Akaike's Information Criterion
Chi2= Chi-square value
Df= Degrees of freedom

AIC
81.099
79.099
80.794
92.697
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chi2
2.454
0
1.695
15.558

df
3
1
1
2

p-value
0.4837
1.000
0.1929
0.0004

analysis showed that age had the most significant influence on micronuclei frequencies
(p<0.00000043). Therefore, an age-corrected univariate assay was performed to evaluate
the effect of other potential influences. The age-corrected analysis showed a significantly
increased frequency of micronuclei to be associated with a history of allergies (Table 3)
and with the consumption of vitamin E supplements (Table 4), with a borderline
significance value being observed for body mass index (BMI) (which led to a tendency
for increased micronuclei frequencies). In contrast, a significantly decreased frequency of
micronuclei was associated with eating fruit (at least 5 days per week); green vegetables
(at least 5 days per week); or folate-supplemented bread (at least 5 days per week) (Table
4).
Surprisingly, a significantly decreased frequency of micronuclei was also noted
for people reporting a history of heart disease and arthritis (Table 3). Given that most of
the individuals who reported having heart disease and arthritis also reported taking
medication to treat these conditions, the effect that these medications might have on
micronuclei frequencies was evaluated. Medication groups used by less than 4
individuals were not analyzed due to the small sample size. Individuals who reported
taking angiotensin converting enzyme (ACE) inhibitors for treatment of their heart
disease had a significantly lower frequency of micronuclei compared to individuals who
did not report taking these medications (Table 5). In contrast, diuretics usage was
associated with a significantly higher frequency of micronuclei (Table 5).
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Table 3. Age-corrected univariate regression analysis of association of
health history factors with lymphocyte micronuclei frequencies.
Health History Predictor

N

Arthritis
Yes
15
No
84
Migraines
Yes
17
No
82
High Blood Pressure
Diagnosed
27
Not Diagnosed
78
Cancer
History of cancer
16
Never had cancer
89
Heart Disease
Diagnosed
11
Not Diagnosed
94
Allergies
Yes
44
No
55
BMI
Obese
19
Overweight
21
Normal weight
43
Underweight
14
*Statistically significant (p<0.05)

MN
Frequency/1000
binucleates
(mean ± s.e.)

MN
Age
adjusted

12.3 + 1.3
12.3 + 0.8

Beta
Estimate

Std.
Error

p-value

-3.9 + 1.2
0.2 + 0.7

-0.4348

0.1242

0.0005*

12.6 + 1.6
12.2 + 0.8

-0.4 + 0.7
-0.3 + 1.2

0.0537

0.1167

0.645

17.9 + 1.8
11.2 + 0.8

1.7 + 1.8
-0.7 + 0.7

0.1103

0.1414

0.435

16.3 + 2.3
12.2 + 0.8

-0.3 + 2.4
-0.1 + 0.7

-0.0814

0.1192

0.495

16.8 + 1.2
12.4 + 0.9

-0.7 +1.4
0 + 0.8

-0.1535

0.074

0.0381*

14.1 + 1.3
10.8 + 0.7

0.8 + 1.2
-1.4 + 0.6

0.1306

0.042

0.0019*

14.8 + 1.9
16.5 + 1.8
10.6 + 0.8
8.25 + 1.3

0.8 + 1.2
1.3 + 1.8
-1.8 + 0.7
-0.2 + 1.3

0.1045

0.0585

0.0742
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Table 4. Age-corrected univariate regression analysis of association of
lifestyle factors with lymphocyte micronuclei frequencies.
Lifestyle Predictor

Tobacco
Past and current users
Non-users
Alcohol
Alcoholic
Everyday
Few times per week
One per week or less
Never
Fruit
5 days per week or more
less than 5 days per week

N

MN
Frequency/1000
binucleates
(mean ± s.e.)

MN
Age
adjusted

23
82

16.0 + 2.1
12.0 + 0.8

2
6
8
23
59
64
35

Beta
Estimate

Std.
Error

p-value

1.5 + 1.9
-0.5 + 0.7

0.0004

0.1002

0.996

15 + 0.5
14 + 3.7
11.7 + 1.5
14.9 + 1.6
10.9 + 0.9

0.1 + 3.6
0.4 + 4.6
-1.8 + 2.0
1.2 + 1.4
-1.1 + 0.8

-0.0032

0.0443

0.942a

11.3 + 0.7
14.1 + 1.6

-1.5 + 0.6
1.5 + 1.4

-0.211

0.0877

0.0162*

-0.1377

0.0743

0.064

-0.2979

0.088

0.0007*

0.1283

0.1135

0.258

0.0389

0.0985

0.693a

0.264

0.1179

0.0251*

0.082

0.1143

0.473

0.0928

0.1067

0.384

0.3149

0.1114

0.0047*a

Folate enriched bread
5 days per week or more
49
10.6 + 0.8
-1.9 + 0.7
less than 5 days per week
50
13.9 + 1.2
1.0 + 1.1
Leafy Green Vegetables
5 days per week or more
37
10.6 + 0.8
-3.0 + 0.7
less than 5 days per week
62
13.3 + 1.0
1.1 + 0.9
Vitamin C supplement
5 days per week or more
12
16.1 + 2.5
0.2 + 2.4
less than 5 days per week
87
11.8 + 0.7
-0.5 + 0.7
Calcium Supplement
5 days per week or more
21
14.1 + 1.3
-1.0 + 1.1
less than 5 days per week
78
11.8 + 0.8
-0.3 + 0.8
Vitamin E supplement
5 days per week or more
10
18.4 + 4.1
2.6 + 4.1
less than 5 days per week
89
11.6 + 0.6
-0.8 + 0.6
Vitamin D supplement
5 days per week or more
14
15.5 + 2.2
0.3 + 2.0
less than 5 days per week
85
11.8 + 0.8
-0.5 + 0.7
Fish Oil supplement
5 days per week or more
15
14.8 + 2.4
-0.1 + 2.3
less than 5 days per week
84
11.8 + 0.7
-0.5 + 0.6
Multivitamin
5 days per week or more
35
15.3 + 1.1
-0.1 + 1.1
less than 5 days per week
64
10.6 + 0.9
-0.6 + 0.8
*Statistically significant (p<0.05)
a
association varies with age, see covariate model Table 6
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To determine if the observed differences in micronuclei frequencies of people
having allergies or arthritis might also be confounded by medications used for their
treatment, lists of medication usage for these conditions were also tabulated. However,
the sample sizes of individuals taking medication for these conditions (only 4 of the 44
individuals having allergies and only 4 of the 15 individuals having arthritis) was too
small to allow for an unbiased statistical assessment.
The micronuclei frequencies associated with three of the variables tested (alcohol
use, multivitamin supplements, and calcium supplements) varied with age. As a result, a
covariate model was used to test for potential associations for these variables. These
covariate assays showed both alcohol intake (moderate) and multivitamin use to be
associated with decreased micronuclei frequencies (Table 6). However, no significant
change in micronuclei frequencies was detected for calcium supplement usage
(borderline value).
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Table 5. Age-corrected univariate regression analysis of association of
medications with lymphocyte micronuclei frequencies.
Medication

N

ACE inhibitor
Yes
7
No
92
 Blocker
11
Yes
88
No
Calcium Channel Blocker
Yes
4
No
95
Angiotensin II Receptor
Blocker
Yes
5
No
94
Diuretic
Yes
10
No
89
* statistically significant (p<0.05)

MN
Frequency/1000
binucleates
(mean ± s.e)

MN
Age
Adjusted

Beta
estimate

Std.
Error

p-value

18.1 + 1.0
11.6 + 0.8

-0.59 +1.4
-0.41 + 0.7

-0.4467

0.1802

0.0132*

16.3 + 1.2
12.1 + 0.7

1.72 + 1.3
-0.69 + 0.7

0.2746

0.1630

0.0920

15.3 + 3.1
12.1 + 0.7

-0.05 + 1.3
-0.43 + 0.7

0.1672

0.1772

0.3453

21.3 + 3.0
11.3 + 0.7

-0.58 + 3.5
-0.41 + 0.7

-0.1142

0.1794

0.5243

17 + 1.5
12.0 + 0.8

-6.07 + 2.8
-1.14 + 0.6

0.4638

0.1261

0.0023*
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Table 6. Covariate regression analysis of association of health
history/lifestyle factors with lymphocyte micronuclei frequencies and age.
Health History Beta Estimate Std. Error
z-value
p-value
or Lifestyle
Predictor
0.013
0.007
1.818
0.069
Calcium
Supplement
-0.008

0.002

-3.390

0.001*

-0.012
Multivitamin
* Statistically significant

0.006

-1.954

0.050*

Alcohol
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Discussion

The frequencies of spontaneous micronuclei observed in the adults (mean age of
55) of this twin population (which ranged from 0.25% to 4.5%) were comparable to the
frequencies observed in singletons having a similar mean age (58) that were studied by
other investigators (range of 0.2% to 4.2%) (Bonassi et al., 2001), suggesting that the
twins who were evaluated in this investigation are representative of the general
population. As noted by others, a strong positive correlation was present between
micronuclei frequencies and age (Bolognesi et al., 1999; Bonassi et al., 2001).
Interestingly, our observation of a peak in micronuclei frequencies in the members of our
60-69 year-old age group (1.1% to 4.5%) is also a finding that has been seen by other
investigators, who have shown that the frequency of micronuclei appears to peak between
ages 50-69, remaining either unchanged or slightly lower in the individuals who live to
be 80 or older (Wojda and Witt 2003; Bolognesi et al., 1997). In contrast to our data,
which showed no effect of sex on the micronuclei frequencies observed over all the
individuals studied, several researchers have reported a difference in micronuclei
frequencies between adult men and women, with women usually having higher
micronuclei frequencies than men (Bonassi et al., 2001). The reason for this contrasting
observation is not clear, but may reflect the fact that our data set included individuals
from a broader range of ages than those typically studied. For example, 9 of the 22 study
groups included in the Human Micronucleus Project (HUMN) found a higher frequency
of micronuclei in males, and two of those studies also included children (Bonassi et al.,
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2001). Additionally, a study by Bonassi et al. (1995) saw a dramatic increase in female
micronuclei frequencies, but this increase was limited to women in age groups over 44
years. When one examines the mean micronuclei frequencies of the 20 to 40 year-olds
and the 50 to 70 year-olds from our study, which are the age groups most frequently
included by others, the micronuclei frequencies of the females tend to be higher than
those of males.
Little information is available about micronuclei frequency rates in children.
However, in their meta- and pooled analyses of baseline levels of micronuclei
frequencies, Neri, et al. (2005) found the average micronuclei frequency in children age
0-18 years to be 0.52% + 0.51%. The average micronuclei frequency in the children
participating in our study was 0.70% + 0.07%. However, our study included children
ages 7 to 18 years, while approximately 30% of the children in their study were younger
than 7 years. Given that an age effect on micronuclei has been shown, even in the first
two decades of life, this variation in frequencies seems likely to reflect the variation in
study subject ages between investigations (Neri et al., 2003). Neri, et al. (2005) also
found no gender effect on micronuclei frequencies in children, consistent with our
observations.
Since micronuclei frequencies are increasingly used as a biomarker, it is
important to know what factors influence their spontaneous frequency. By studying
twins, we were able to provide the first estimate of the proportion of variation in
micronuclei frequencies that was attributable to unique environmental, common
environmental, and/or additive genetic effects. Interestingly, the ACE model fitting
analyses, which were completed on age-adjusted data to account for the strong
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correlation present with advancing age, showed the best fit for reduced models, in which
the variation was best explained by both common environmental and unique
environmental factors (CE); or by additive genetic and unique environmental factors
(AE). Both of these models (AE or CE) provided a significantly better fit than models
attributing the observed variation to only additive genetic effects or only unique or
common environmental exposures. Similarly, the MZ (0.5) and DZ (0.42) twin
correlation coefficients provided values that clearly showed the presence of an
environmental influence, but did not readily allow one to discriminate between the
additional effects arising from additive genetic versus common environmental influences.
Thus, the frequency with which an individual forms micronuclei appears to be a complex
trait that is determined by a mixture of unique environmental influences, as well as either
additive genetic or common environment exposures. Our continued studies of a larger
number of twins should allow us to better recognize the contribution of environmental
and/or genetic influences to the formation of micronuclei in humans.
Although unique environmental effects do not appear to solely influence
micronuclei frequencies, they were consistently shown to contribute to the observed
variation in frequencies. Therefore, data from the health history questionnaires were
analyzed to determine if specific environmental/health factors could be identified that
were consistently associated with an increased or decreased frequency of micronuclei.
Of the 7 health conditions that were assessed (Table 3), only three conditions (heart
disease, arthritis, and allergies) were shown to be significantly associated with
micronuclei frequencies after age adjustment. Specifically, individuals with allergies had
substantially larger micronuclei frequencies compared to individuals without allergies,
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while individuals who reported arthritis or heart disease had significantly lower
micronuclei frequencies compared to individuals without these conditions.
The assessment of heart disease in this study cohort was compromised because it
was self-reported and the study participants differed in their inclusion criteria. Some
individuals reported having heart disease because they had high cholesterol levels or high
blood pressure, or both, while others only reported heart disease if they had experienced a
heart attack. Because of this complication, the data were less subjectively analyzed by
evaluating these individuals based on the medications that were prescribed for treatment
by their physician. The medications that were used by 4 or more individuals included
ACE inhibitors, beta blockers, calcium channel blockers, angiotensin II receptor blockers,
diuretics, statins, and aspirin. Of the more commonly used medications, ACE inhibitors
were found to be associated with significantly decreased micronuclei frequencies
(p=0.013), while diuretics were associated with significantly increased micronuclei
frequencies (p=0.0002) (Table 5). These findings are in agreement with previous results
that showed the use of diuretics in vitro (specifically hydrochlorothiazide) was associated
with increased micronuclei frequencies (Andrianopoulos et al. 2006), while ACE
inhibitors (specifically Captopril) significantly decreased micronuclei frequencies
(Hosseinimehr et al., 2007). However, in this latter study, micronuclei frequencies were
assessed in bone marrow cells from mice following irradiation, with no other studies in
humans being reported.
Although the sample size of this study (n=115 individuals) was smaller than that
used by some other investigators whose primary aim was to identify potential dietary and
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lifestyle influences on micronuclei frequencies (reviewed in Battershill et al., 2008),
significant differences were observed for both dietary patterns and alcohol usage.
The regular inclusion (at least 5 days per week) of fruit and leafy green vegetables
in the study participants’ diet was associated with a significant decrease in their
micronuclei frequencies. In addition, a trend toward a reduced frequency of micronuclei
was observed for people reporting a consistent intake of folate-enriched bread.
Collectively, these data suggest that folate may be important for regulating micronuclei
frequencies, providing a “protective” effect that is associated with a decrease in
frequency. This finding confirms the observations of other researchers, who have also
reported folate usage to be associated with decreased micronuclei frequencies (Fenech
2001; Fenech 2002; Fenech et al., 2005; Fenech and Rinaldi, 1994; AbramssonZetterberg et al., 2006; Fenech 1998; Titenko-Holland et al., 1998). Given that folate is
required for DNA synthesis and repair, with it acting as a methyl donor for thymidylate
synthesis, it is understandable that increased folate ingestion is associated with decreases
in micronuclei frequencies (Fenech 2001).
The influence of ingesting supplemental vitamins was also evaluated. Of the
vitamins assessed (C, E, D, calcium, fish oil/omega 3 fatty acids, and multivitamins) only
vitamin E and multivitamin ingestion were found to significantly influence micronuclei
frequencies. The use of vitamin E supplements was associated with an increased
frequency of micronuclei. Other investigators who have studied this effect have reported
varied results, with increases, decreases and no effect being seen for Vitamin E and C
ingestions and micronuclei frequencies (Battershill 2008). Interestingly, Fenech, et al.
(2005), observed a decreased frequency of micronuclei with vitamin E intake, but did
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note an increased frequency of micronuclei with biotin, riboflavin and pantothenic acid
ingestion. It is also interesting to note that vitamin E is found in many fruits and leafy
green vegetables (along with folate, iron, calcium, and vitamins A, K, C), yet our sample
showed a decreased frequency of micronuclei associated with their consumption. Thus,
the protective influence conferred from the ingestion of these fruits/vegetables may arise
primarily from the other components (such as folate), or the effect of vitamins may be
varied depending on whether they are ingested as a supplement (perhaps over usage)
versus ingested as a component of natural foods.
In addition to looking at individual vitamins, multivitamin use was evaluated and
found to be associated with a decreased frequency of micronuclei (with the effects covarying with age). The individual components of the daily multivitamins were not
reported, so we are unable to directly associate the positive effects to a key component(s).
The effect of tobacco and alcohol usage on micronuclei frequencies of the adults
who participated in this study was also evaluated. Like several investigators (specifically
the HUMN project which included over 5000 individuals), we found tobacco usage to
have no significant influence on micronuclei frequencies (Bonassi et al., 2001).
However, the study results of other investigators have shown an increased frequency of
micronuclei with tobacco usage (Fenech 1993; Schneider et al., 2001), suggesting that the
effect, if present, may vary with specific products consumed or be influenced by other
factors (such as diet or other susceptibility factors).
The association of alcohol use on the micronuclei frequencies of the adults in this
study was shown to co-vary with age. In the covariate model factoring age effects,
alcohol use was shown to be associated with decreased micronuclei frequencies. While
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the generalized effect of alcohol on micronuclei frequencies has been noted to provide
varied results (Battershill 2008), researchers have consistently found an increased
frequency of micronuclei with alcohol use in individuals having genetic variants in the
alcohol metabolizing enzyme, alcohol dehydrogenase (Ishikawa et al., 2006; Kim et al.,
2005). Teo and Fenech (2008) suggest an interaction between folic acid and alcohol use,
where increased folic acid protects against the DNA damage caused by increased ethanol
use. However, a factor confounding the interpretation of an association between alcohol
consumption and micronuclei frequencies in this current study, as well as studies
completed by other investigators, is the potential variation in the effect of moderate to
low alcohol use (which may have no effect) compared to excessive alcohol usage, the
latter of which has been associated with the presence of increased frequencies of
micronuclei (Castelli et al., 1999; Maffei et al., 2002).
In summary, the frequency of spontaneously arising micronuclei in humans
appears to be a complex trait that is influenced by unique environmental factors as well
as other factors (such as additive genetic or common environmental effects). Recognition
of the factors contributing to the baseline level of micronuclei is important for helping to
better design studies that include the assessment of micronuclei frequency data for
evaluating agents hypothesized to influence genomic instability.
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Chapter 3.

The numerical contents of sex chromosome containing micronuclei and the
corresponding binucleates

Introduction

DNA damage and chromosomal instability are commonly associated with
disease; most notably cancer. The cytockinesis-blocked micronculeus (CBMN) assay
has become one of the most frequently used tools for assessing chromosomal
abnormalities that have been acquired in the somatic cells of an individual, particularly
in response to environmental exposures (Fenech 2006; Battershill et al., 2008). The
popularity of this assay stems, in part, from its ability to provide an accurate alternative
to the time consuming process of identifying chromosomal damage through the analysis
of individual metaphase spreads. Briefly, by scoring micronuclei (which are small
chromatin-containing structures that were not incorporated into daughter nuclei
following cell division), the CBMN assay provides information regarding the frequency
of chromosomal aberrations present in somatic cells prior to the influences of selective
growth pressures (Fenech and Morley, 1985). Thus, this technique is helpful in
identifying genotoxic agents.
Studies from the Human Micronucleus (HUMN) consortium have shown
advancing age to be consistently associated with an increased frequency of spontaneously
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occurring micronuclei in adults (Bonassi et al., 2001). However, the underlying
mechanisms leading to this age-related increase are not known. One approach that
investigators have used to gain insight about the underlying chromosomal errors that
result in the formation of micronuclei has been to characterize their chromatin content to
determine if consistent patterns emerge. While one cannot directly visualize
chromosomes in micronuclei, their chromatin content can be inferred using fluorescence
in situ hybridization methodologies (Norppa and Falck, 2003). Through the use of
pancentromeric and pantelomeric probes, investigators have inferred that the majority of
spontaneously occurring micronuclei contain a single, intact chromosome (Leach and
Jackson-Cook, 2001; Wojda and Witt, 2003; Lindberg et al., 2008). Furthermore, in
adults the sex chromosomes (chromosomes X and Y) are most frequently excluded into
micronuclei, with this frequency increasing with age (Norppa and Falck, 2003). While
these studies have provided information for adults, very few of these investigations have
included children, in part due to their low frequency of micronuclei. In one such study, in
which the micronuclei present in the cells from 10 children (5 males and 5 females) were
evaluated, Guttenbach et al. (1994) found 8% of micronuclei in females (ages 1-10 years)
to contain X chromatin, with Y chromatin being present in 14% of the micronuclei in
males (ages 0.5-4 years). Hando et al. (1994) and Nath et al. (1995) found no
micronuclei containing sex chromosomes in the newborns they studied. Thus, little is
known about the age at which the apparently preferential exclusion of sex chromosomes
into micronuclei is initiated in humans.
Therefore, the primary aim of this study was to determine if there is a difference
in the proportion of micronuclei that contain sex chromosomes in adults (19-81 years)
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compared to children (7-15 years). This goal was achieved by scoring the number of
centromeric signals present in micronuclei and their corresponding binucleates using
probes specific for the pericentromeric regions of the X and Y chromosomes.
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Materials and Methods

Sample Ascertainment
A total of 59 individuals (37 males and 22 females) were ascertained through the
Mid-Atlantic Twin Registry, which is based at Virginia Commonwealth University. The
individuals included in this study were selected from a larger, ongoing twin study, with
their selection being: (1) random (n= 8); or (2) based on the individual having 5% or
more of their micronuclei that contained chromatin from a sex chromosome [as
ascertained from our studies using spectral karyotyping (n= 51) (see chapter 4)]. After
providing informed consent (VCU IRB protocol 179), participants submitted blood
samples. The peripheral blood specimens were drawn by the study participant’s health
care provider and shipped to our laboratory via an overnight delivery carrier.

Cell Culture
The cultures to assess micronuclei frequencies were established with lymphocytes
[using Histopaque-1077 (Sigma)] according to the protocol of Fenech (1993). Briefly,
cytochalasin B (3.0 μg/ml; Sigma, 14930-92-2) was added to the cells 44 hours after
culture initiation. At 72 hours, binucleate interphase cells were harvested using standard
techniques, which included a 10-minute incubation in hypotonic solution (0.075 M KCl),
and serial fixation (three times using a 3:1 methanol: acetic acid solution). Slides were
made following standard procedures (Leach and Jackson-Cook, 2001).
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FISH Procedure
For males, the sex chromosomal contents of the micronuclei were determined
through the simultaneous hybridization of 3 differentially colored probes according to
standard procedures (Abbot Molecular). The pericentromeric probes used included ones
specific for the X chromosome (DXZ1; Spectrum Aqua); the Y chromosome (DYZ3;
Spectrum Orange); and chromosome 17 (D17Z1; Spectrum Green), with the latter probe
being used as an autosomal control. For females, the same X (DXZ1) and autosomal
(D17Z1) probes were used, but the Y chromosomal probe was not evaluated since
previous GTG-banding studies confirmed that none of these females had a Y
chromosome. The target (interphase chromatin) and probe DNA were denatured
separately. The chromatin on the slides was denatured using a 70% formamide solution
(pH 7.0) at 73C for 3 minutes. Following denaturation, the slides were briefly rinsed in
cold water and then dehydrated using an ethanol series (70%, 85%, and 100% for 2
minutes each). The probes (which were prepared using a 1:100 dilution in a C-Denhyb
solution, Insitus Biotechnologies, Albuqueque, New Mexico) were denatured at 94C for
10 minutes, and then cooled on ice for 2 minutes. Following the addition of the
denatured probe to the denatured slide, the slides were placed in a humidified chamber
and hybridized at 37C overnight. Non-specific binding of probes was removed by
washing in a 0.4xSSC/0.3%NP-40 solution at 73 for 2 minutes, followed by a one
minute wash at room temperature in a 2xSSC/0.1%NP-40. To visualize the binucleates
and micronuclei, the slides were counterstained with DAPI II (Abbott).
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FISH scoring
Slides were scored on an Axioskop equipped with triple- and single-band pass
filters (Zeiss). Only binucleates that contained one or more micronuclei, as visualized
with DAPI staining, were scored. Following their identification, the number of
fluorescent signals for each probe in the binucleates and micronuclei were scored (Figure
5). Representative images of the cells having micronuclei were captured using an image
analysis system (Applied Spectral Imaging, Carlsbad, CA).

Statistics
The number of signals present in the micronuclei were evaluated for consistent
patterns. Given that the frequencies of the micronuclei were not normally distributed, a
square root transformation of the data was performed. Following transformation, the
proportion of patterns present in the children and adults was determined using a general
linear modeling (GLM) analysis [ =0.05; R (Version 2.9.1) software analysis system].
Gender and age were factors that were evaluated in the model.
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(a).

(b)

Figure 5. Representative images of binucleates and their micronucleus
following FISH. The cells shown are from two males. (a) The micronucleus in
this image contains chromatin from the Y chromosome (orange signal). The
upper binucleate contains one aqua signal (X chromatin) and two green signals
(17 chromatin), while the lower binucleate has one orange signal (Y chromatin),
two green signals (17 chromatin), and one aqua signal (X chromatin). This
binucleate was scored as having a hypodiploid cell pattern. (b) This
micronucleus contains two orange signals (Y chromatin). The corresponding
binucleate was scored as euploid because both cells have a normal complement
for the chromosomes evaluated (1 aqua, 2 green, and 1 orange signal).
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Results
Cellular distribution of sex and autosomal probe signals
Following hybridization, a total of 2,749 micronuclei were scored from the 37
male study participants, with 13.2% of the micronuclei containing Y chromatin, 5.7%
containing X chromatin, and only 1.5% having chromatin from chromosome 17. For all
three chromosomes scored (X, Y, and 17), the majority of micronuclei appeared to
contain a single centromeric region (51.9%, 58.8%, and 92.9%, respectively). Similarly,
of the 1,868 micronuclei scored from the 22 female study participants, 15.8% contained
chromatin from the X chromosome, with only 2.1% having chromatin from chromosome
17. As in the males, the majority of micronuclei in the females appeared to contain a
single centromeric region of the chromosome scored (54.4% for the X chromosome, and
92.1% for chromosome 17).
The probe signal patterns present in the total of 1,017 binucleated cells having at
least one micronucleus with a signal for chromosomes X, Y, or 17 revealed the presence
of three primary types of cells as shown in Figures 6, 7, 8, and 9. These consistently
observed cell types included those having binucleates with: (1) a hyperdiploid
complement [having one or more additional signals when compared to euploid
expectations (X,Y,17,17 or X,X,17,17) in at least one binucleate], with the chromosomal
region involved in the imbalance also being present in the micronucleus; (2) a
hypodiploid complement in at least one binucleate (missing a signal for one of the
chromosomal regions evaluated), with the missing signal being excluded into the
micronucleus; or (3) a euploid binucleate complement, with an apparent chromosomal
imbalance being “corrected” through its exclusion into the micronucleus.
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Overall, the hypodiploid binucleate cell type was seen most frequently (63.2% of
total), followed by the euploid binucleate pattern (28.7%) and the hyperdiploid cell type
(8.1%). This pattern was found for each chromosome analyzed (Figure 6).

Binucleate FISH and age
To determine if the proportion of binucleate/micronuclei patterns varied with age
or gender, a general linear model (GLM) analysis was completed. In the males, the
percent of cells having the “corrected” euploid binucleate micronuclear pattern for the Y
chromosome significantly decreased with age (p=0.026), while those having a
hypodiploid binucleate pattern tended to increase with age (Figure 7). Similarly, in the
females, the proportion of cells having a “corrected” euploid binucleate micronuclear
pattern for the X chromosome was significantly decreased with age (p=0.030), while the
proportion of cells having a hypodiploid binuclear complement tended to increase with
advancing age (Figure 8). In contrast, for the males, no significant divergence in the
proportion of binucleates having an unbalanced (hyperdiploid or hypodiploid) or
balanced complement for the X chromosome was observed with age (p=0.45) (Figure 9).
Moreover, no significant difference in the proportion of hyperdiploid binucleates was
observed for the X (males or females) or Y chromosome (males) (Figures 7, 8, and 9).
The number of micronuclei containing chromatin from chromosome 17 (total of 81) was
too small to allow for a meaningful statistical analysis of age-related patterns for this
autosome.
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(a)

Males

(b)

Females
X chromosome

Hypodiploid
n=190

n=269

Chromosome 17

Hyperdiploid
n=41

n=38
Y chromosome

Euploid
“Corrective”

Hyperdiploid
Hypodiploid
Euploid

n=479

Figure 6. Primary patterns observed in binucleates and micronuclei. (a) The three
generalized types of combinations of binucleates observed are shown as they appear
for the Y chromosome (for the X chromosome see figures 8 and 9) (b) The proportion
of total cells (all study subjects) having each of the three cellular patterns
[hyperdiploid (gray); hypodiploid (white); and euploid (black)] in males and females
are shown for each chromosome (n=number of binucleates scored for each
chromosome/gender).
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Figure 7. Percent of each binucleate type for the Y chromosome by age.
The bar graph represents the percentage of binucleates that were
hyperdiploid (gray), hypodiploid (white), and euploid (black). The age
groups evaluated are shown on the X axis, with the percentage of binucleates
being shown on the Y axis.
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Figure 8. Percent of each binucleate type for the X chromosome by age in
females. The bar graph represents the percentage of binucleates that were
hyperdiploid (gray), hypodiploid (white), and euploid (black). The age groups
evaluated are shown on the X axis, with the percentage of binucleates being shown on
the Y axis.
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Figure 9. Percent of each binucleate type for the X chromosome by age
in males The bar graph represents the percentage of binucleates that were
hyperdiploid (gray), hypodiploid (white), and euploid (black). The age
groups evaluated are shown on the X axis, with the percentage of binucleates
being shown on the Y axis.
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Discussion

In order to better understand the underlying basis for the observation of an agerelated increase in sex-chromatin containing micronuclei, we evaluated micronuclei and
their corresponding binucleates from males and females of varying ages. We expanded
upon previously reported data by analyzing the number of signals that were present for
the pericentromeric region of the sex chromosomes (as well as an autosome) in the
binucleates, in addition to their corresponding micronuclei. The most frequently observed
pattern that was detected in the study participants resulted in a hypodiploid sex
chromosomal complement in a binucleate(s), as a result of the exclusion of that
chromosome into a micronucleus. This finding is in agreement with the results of
Hando, et al. (1994), who included a description of the binucleate signal patterns in their
study of micronuclei containing X chromatin. In the adult females they studied, who
ranged in age from 20 to 79 years, the only patterns reported were those resulting in a
hypodiploid binucleates. While these investigators also obtained blood samples from 8
newborns, those samples were excluded from their X chromatin FISH studies due to the
low frequency of micronuclei present. In contrast to their results, we also observed
patterns resulting in hyperdiploid complements, as well as euploid complements in the
binucleates.
Of particular interest was this latter category, in which the exclusion of a sex
chromosome into a micronucleus resulted in the establishment of a balanced complement
for the binucleate (possible trisomy rescue). The proportion of these “corrective” cells
was significantly increased in the younger compared to older females and males for the X
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and Y chromosomes, respectively. This age-related divergence in cell type pattern also
included a trend toward an increase in the proportion of binucleates having loss for a sex
chromosome (Y in males; X in females) in the older study subjects.
One can theorize that the “corrective” cells observed in this study might have
arisen from a mitotic error, possibly caused by DNA damage and/or aneugenic
environmental exposure, and that the formation of the micronucleus resulted from the
ability of the cell cycle checkpoints (or alternative mechanisms) to correct this error.
These processes may be less effective for detecting abnormalities resulting in
chromosomal loss versus gain and/or may decrease in efficiency with age. Thus, the agerelated changes that arise from loss mechanisms lead to an overall age-related increase in
the frequency of micronuclei. Given the paucity of micronuclei containing chromosome
17 in this study, we were unable to determine if this phenomenon is true for autosomes,
as well as sex chromosomes.
In summary, the pattern of sex chromosomal imbalance in binucleates containing
a micronucleus varies with age. In addition to reflecting the presence of cell loss, which
appears to be an age-related change, the presence of micronuclei may reflect a “trisomy
rescue” event. While this information supports the conclusion that micronuclei
frequencies serve as an indication of DNA damage and/or imbalance, in some cases,
particularly when seen in children, their presence may also represent the cell’s ability to
correct for acquired damage. Therefore, when analyzing micronuclei frequencies, it may
be informative to examine the contents of the binucleates, in addition to the micronuclei,
to facilitate the recognition of varying cellular responses to environmental or genotoxic
exposures.
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Chapter 4.

Chromosomal contents of micronuclei determined using SKY

Introduction
Micronuclei frequencies are known to increase with age and have been
associated with increased DNA damage.

The cytokinesis-blocked micronucleus

(CBMN) assay has become a useful tool for assessing micronuclei frequencies. While
there is increasing information on the frequencies of micronuclei, there is minimal data
regarding the chromosomal contents of the micronuclei. While one cannot directly
visualize chromosomes in micronuclei, their chromatin content can be inferred using
fluorescence in situ hybridization methodologies (Norppa and Falck, 2003). Through
the use of pancentromeric and pantelomeric probes, investigators have determined that
the majority of spontaneously occurring micronuclei contain a single, intact
chromosome (Leach and Jackson-Cook, 2001; Wojda and Witt, 2003; Lindberg et al.,
2008). In an attempt to determine the chromosomal contents of micronuclei, several
investigators have used probes that are specific for the sex chromosomes (either
centromeric probes or painting probes), with small subset of autosomes being evaluated,
including chromosomes 1, 2, 9, 11, 16, 21, and 22 (reviewed by Norppa and Falck,
2003). Of the chromosomes evaluated, the sex chromosomes have been the most
frequently observed chromosome present in the micronuclei, with their frequencies
increasing with age (reviewed by Norppa and Falck, 2003). However, the vast majority
of the existing data has been collected from assessments of micronuclei present in
adults, and the few studies that have investigated the chromosomal contents of
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micronuclei in children have limited sample sizes, with the number of children studied
ranging from 8 to 18 (Guttenbach et al., 1994; Hando et al., 1994; Nath et al., 1995).
Technological problems that have been encountered by investigators striving to
determine the chromosomal contents of micronuclei have included: (1) incomplete
characterization of the chromatin present in the micronuclei since enumeration probes
generally hybridize only to chromatin including the centromere region (thus providing
no information for micronuclei containing acentric fragments); and (2) the number of
chromosomes that can be evaluated using a whole chromosome painting approach (or a
centromeric probe approach) is limited due to a small number of differentially labeled
probes. Thus, the data pertaining to autosomal inclusion in micronuclei, which has been
gained through these techniques, is inconclusive. Two groups (Tucker et al., 1996;
Fauth et al., 1998 and 2000) reported that chromosome 9 was frequently excluded into
micronuclei. However, Tucker, et al. (1996) based this conclusion on only the
observation of two chromosome 9 positive micronuclei (from a total of 96 evaluated),
and Fauth, et al. (1998, 2000) completed their study using only three individuals. Yet
another investigative team reported that chromosome 2 was present in micronuclei with
an increased frequency, but this conclusion was based on studies completed from a
single individual (Peace et al., 1999).
To circumvent the methodological problems of determining the chromosomal
contents of micronuclei arising from conventional FISH methodologies, Leach and
Jackson-Cook (2001) developed a novel assay exploiting spectral karyotyping (SKY)
technology for the detection of chromosome contents in micronuclei. This approach
offered a huge advantage over the two previously used techniques since SKY allowed
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for the simultaneous detection of all 24 chromosomes.

However, like other

investigations, this initial study was based on the assessment of only three females.
Therefore, the primary aim of our study was to expand upon previous work and
determine the baseline frequency with which sex chromosomes, as well as autosomes,
are excluded into micronuclei by analyzing the chromosomal contents of micronuclei in
males and females through the use of spectral karyotyping, while simultaneously
determining if the pattern of chromosome involvement varied with age.
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Materials and Methods

Sample Ascertainment
A total of 79 individuals (42 males and 37 females) were ascertained through the
Mid-Atlantic Twin Registry, which is based at Virginia Commonwealth University. The
frequency of micronuclei was determined for each of the 115 study participants according
to the protocol of Fenech (2003). Spectral karyotyping was performed on those
individuals having 0.4% or higher frequency of micronuclei. After providing informed
consent (VCU IRB protocol 179), participants submitted blood samples. The peripheral
blood specimens were drawn by the study participant’s health care provider and shipped
to our laboratory via an overnight delivery carrier.

Cell Culture
Lymphocytes were isolated using Histopaque-1077 (Sigma) and lymphocyte
cultures were established according to standard procedures (Moorhead et al. 1960).
Cytochalasin B (Sigma, 14930-92-2) was added to the cultures 44 hours after initiation at
a concentration of 3.0 μg/ml. Cultures were harvested at 72 hours. Cells were treated
with hypotonic solution (10 minutes with 0.075 M KCl), and fixed three times (3:1
methanol: acetic acid). Slides were made following standard procedures (Leach and
Jackson-Cook, 2001), and aged at room temperature for four days before beginning the
SKY procedure.
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Spectral Karyotyping
SKY was performed according to the manufacturer’s (Applied Spectral Imaging)
protocol. Briefly, the chromatin on the slides was denatured using a 70%
formamide/2xSSC solution (pH 7.0) at 73C for 2 minutes. Following denaturation, the
slides were briefly rinsed in cold water and then dehydrated using an ethanol series (70%,
85%, and 100% for 2 minutes each). The SKY probe (Applied Spectral Imaging) was
denatured at 75C for 10 minutes, followed by suppression hybridization at 37C for 60
minutes. Following the addition of the denatured probe to the denatured chromatin, the
slides were placed in a humidified chamber and hybridized at 37C for approximately 44
hours. Non-specific binding of the probe was removed by washing in a
0.4xSSC/0.3%NP-40 solution at 73C for 2 minutes, followed by a one minute wash at
room temperature in a 2xSSC/0.1%NP-40. Indirectly labeled probes (biotin and
digoxigenin) were detected using buffers with avidin-Cy5, mouse anti-digoxin and goat
anti-mouse conjugated to Cy5.5 (provided by manufacturer). All incubations were for 40
minutes at 37C. To visualize the binucleates and micronuclei, the slides were
counterstained with DAPI/Antifade (Applied Spectral Imaging) and viewed using a Zeiss
Axioskop equipped with a DAPI filter and a custom triple-band pass filter (Chroma). For
analysis, the micronuclei were captured using a SpectraCube system (Applied Spectral
Imaging) and analyzed using the SKY software. At least one metaphase spread was
analyzed per slide to ensure proper hybridization of the SKY probe cocktail. Once
proper hybridization was confirmed, each micronucleus, along with the surrounding
nuclei, was captured and analyzed. An example of the captured images is found in Figure
10.
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a.

b.

c.

Figure 10. Representative binucleate and micronucleus following SKY.
These structures are shown as they appear with reverse DAPI staining (a);
the spectral image (b.) and the classified image (c.) The chromatin present in
this micronucleus was determined to have originated from chromosome 11.
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SKY assignment confirmation using FISH (WCP and CEP)
After analysis, slides were randomly chosen to assess the accuracy of the SKY
classification. These slides were washed in 70% formamide/2xSSC solution (pH 7.0) at
70C for 2 minutes to remove the SKY probe. Slides were then stained with DAPI and
viewed to ensure complete removal of the probe. After a brief wash in 2xSSC, the slides
were hybridized with either a whole chromosome painting probe (WCP) or centromere
enumeration probe (CEP). The probes and slides were then co-denatured (75C for 2 min
for WCP or 73C for 2 minutes for CEP). Following co-denaturation, the slides were
placed in a humidified chamber and hybridized at 37C overnight. Non-specific binding
of the probe was removed by washing in a 0.4xSSC/0.3%NP-40 solution at 73C for 2
minutes, followed by a one minute wash at room temperature in a 2xSSC/0.1%NP-40.
Slides were counterstained with DAPI II (Abbott Molecular) and viewed using a Zeiss
Axioskop equipped with triple-band pass and single band pass filter sets (Abbott
Molecular).

Statistical Analysis
Comparisons of the frequencies of chromosomal exclusion into micronuclei were
performed using a contingency Chi-square test. In order to limit type I errors, an alpha
level of p<0.05 was used for all statistical tests.
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Results

Chromosomal contents in Micronuclei
Of the 3,611 micronuclei scored, the majority (89.6%) contained chromatin from
a single chromosome. Micronuclei were most frequently found to contain chromatin
from the sex chromosomes, with 27.3% of micronuclei in females containing X
chromatin and 27.6% of micronuclei in males containing Y chromatin (p<0.0001). A
non-random pattern of autosomal exclusion into micronuclei was also observed
(p<0.0001), with chromosomes 4, 8, and 9 being present most frequently, and
chromosomes 17 and 22 being present least frequently. No significant difference in these
patterns of autosomes were observed between the males and females studied (p=0.7)
(Figure 11).

Micronuclei contents with age
A significantly lower frequency in the proportion of micronuclei containing sex
chromosomes was observed in the children (7-19 years) compared to adults (25-81
years), for both males (p<0.0001) and females (p<0.0001). However, no significant
difference in autosomal patterns was observed with age (p=0.9) (Figures 12 and 13).

SKY accuracy
To determine the accuracy of the SKY methodology for evaluating the
chromosomal contents of micronuclei, a total of 389 micronuclei were re-assessed using
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Figure 11. Distribution of chromosomes excluded into micronuclei in
males (black) and females (white). The percentage of micronuclei (Y
axis) that contained chromatin from each of the chromosomes (X axis) is
shown.
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Figure 12. Distribution of sex chromosomes in micronuclei with age. The
percentage (Y axis) of X and Y chromosomes present in micronuclei seen in
children (black) and adults (gray) are shown. The distribution observed in
males is shown for the X (left histograms) and Y (center histogram)
chromosomes. The distribution observed for the X chromosome in females is
also shown (right histogram).
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Figure 13. Distribution of autosomes excluded into micronuclei
in children (black) and adults (white). The percentage of
micronuclei (Y axis) that contained chromatin from each of the
chromosomes (X axis) is shown.
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single, chromosome-specific probes. Agreement in the chromosomal classification was
present for 83% of the micronuclei scored using centromeric probes, with agreements
being observed for 89% of the micronuclei evaluated using whole chromosome painting
probes. An example of the image captured during these confirmation studies is found in
Figure 14. All cases having a discrepancy failed to show a hybridization signal for the
chromosome evaluated in the micronucleus but did demonstrate sufficient hybridization
of the probes in the binucleate.
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SKY classification

Painting Probes

Figure 14. Representative images showing confirmation of SKY
micronuclei assessment using a painting probe. The image on the left
depicts a micronucleus classified by the SKY software as containing
chromatin from chromosome 4. The image on the right depicts the same
micronucleus after the SKY probe was stripped and the slide was rehybridized with the chromosome painting probes 4 (orange) and 12
(green). The micronucleus hybridized orange, confirming the SKY
classification.
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Discussion

SKY analysis was performed to determine if there was a non-random pattern of
chromosomes excluded into spontaneously occurring micronuclei in healthy individuals.
This technique allows for the examination of all 24 chromosomes in a single
hybridization. The majority of micronuclei were found to contain chromatin from a single
chromosome. In both males and females, the sex chromosomes were most frequently
excluded into micronuclei. Chromosomes 4, 8, and 9 were also found with a significantly
higher frequency than expected by chance, while chromosomes 17 and 22 were found
much less frequently than expected. This preferential exclusion of chromosome 9, which
has been reported previously (reviewed by Norppa and Falck, 2003), is thought to be
related to the large block of heterochromatin on this chromosome; however chromosomes
1 and 16 also contain large blocks of heterochromatin, and these chromosomes were not
found to have an increased frequency. We found no difference in the pattern of
autosomes present in the micronuclei studied from males compared to females. This
observation is consistent with the results of studies reported by Wojda et al. (2007), who
also did not find a gender difference in frequency of micronuclei containing the subset of
autosomes they assessed using FISH techniques.
To determine if age influenced the distribution of specific chromosomes that were
excluded into micronuclei, comparisons were made between adults (ages 25-81 years)
and children (ages 7-19 years). Indeed, a significantly higher proportion of micronuclei
containin sex chromosomes was seen in adults compared to children. This age-related
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difference in sex chromosomal exclusion into micronuclei was observed in both the
males and females. However, no significant differences in the proportion of micronuclei
containing autosomes were detected with age or gender. Wojda et al. (2007) found a
similar effect in adults, noting that the frequency of sex chromosome micronuclei
increased with age, but the frequencies of the five autosomes that they tested
(chromosomes 1,4, 6, 8, and 20) did not vary with age.
Given that the SKY methodology was developed for use on metaphase
chromosomes, with software classification standards being established for a metaphase
format, we performed confirmation studies, using chromosome-specific probes, for a
subset of micronuclei. These studies allowed for an evaluation of the accuracy of this
SKY methodology when used in this interphase cell format. These FISH confirmation
studies, which primarily assessed sex chromosomal assignments, showed agreement
between the FISH and SKY assays for 83% of micronuclei using centromeric
enumeration probes (CEP), and 89% of the micronuclei using whole chromosome
painting probes (WCP). The variation in this number most likely reflects the difference
in the two methods used. The accuracy determined by using the CEP probes was most
likely lower because this probe only allows for confirmation of micronuclei containing
the centromeric region and would not allow for confirmation of micronuclei having
fragments of that chromosome that did not contain the centromere. Therefore, these
studies could produce false negative results (with the SKY software correctly identifying
the chromatin, which originated from a portion of the chromosome without the
centromeric region [thus the CEP probe would not bind]). The agreement in assignment
for 89% of the micronuclei, as confirmed through the use of WCP probes, is expected to
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yield a better estimate the true accuracy of the SKY method, since the whole
chromosome probes will bind to any region of the chromatin. Collectively, these
findings suggest that a fraction of the micronuclei may contain chromosomal fragments.
In conclusion, there is a non-random pattern of chromosome exclusion into
micronuclei, with the sex chromosomes being most frequently involved. The frequency
of autosomes excluded into micronuclei does not appear to vary with age or gender. This
study further demonstrates the usefulness of the SKY method for the detection of
micronuclei chromosomal contents. The frequencies of autosome involvement in
micronuclei detected in this study can serve as normal, baseline data for other
researchers.
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Chapter 5.

Variation in global methylation profiles between identical twin pairs

Introduction

While acquired chromosomal changes in DNA (aneuploidy) were first noted
nearly 50 years ago, it was only recently recognized that chromatin has the potential to
undergo epigenetic changes with advancing age (Sedivy et al., 2008). Epigenetic
modifications, such as DNA methylation, play an important role in the control of gene
expression and chromosome structure (Frigola et al. 2002; Peaston and Whitelaw, 2006).
Simplistically, methylation typically prevents gene expression, while loss of methylation
allows transcription. However, the degree to which one’s methylation profile changes
with age is unresolved, with some researchers reporting that methylation increases with
age while others report an overall decrease in methylation with age (Golbus et al., 1990;
Cooney, 1993; Vertino et al., 1994; Toyota et al., 1999; Geigl et al., 2004; Clayton et al.,
2005; Wojdacz and Hansen, 2006; Bollati et al., 2009). Furthermore, the cause(s) of these
changes in methylation patterns with age, when present, are unknown. Some believe it is
a function of diet and environment, while others believe it to be a random process
(Cooney, 1993; Fenech 2002; Jaenisch et al., 2003; Bjornsson et al., 2004; Peaston and
Whitelaw, 2006). It has been hypothesized that as humans age, they accumulate
epigenetic and/or chromosomal changes over time (Wong et al, 2005; Petronis, 2006).
Once multiple changes are acquired, these alterations may result in the development of an
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age-related complex disease. In fact, many cancer cells have been shown to develop
epigenetic changes, with some cancer types showing alterations that lead to
hypomethylation of genes, while others have shown hypermethylation changes (reviewed
by Iacobuzio-Donahue, 2009). The possible randomness and unpredictable nature of
these modifications in DNA methylation has been proposed to explain the observation of
monozygotic (MZ) twins who are discordant for certain diseases (schizophrenia at 50%
discordance for MZ twins, 70% for rheumatoid arthritis, and 80% for breast cancer),
despite their having no evident differences in environmental exposure (King et al., 1992;
Petronis, 2001; Singh et al., 2002). The observation that there was no difference in the
frequency of phenotypic discordance between MZ twins raised apart when compared to
MZ twins raised together, led Wong et al. (2005) to suggest that the observed phenotypic
divergence reflected a mechanism other than environment, implicating epigenetic
alterations as a possible etiological factor. This hypothesis has gained supported from
several investigators, including Petronis (2001), who suggested that a large number of
epigenetic changes could accumulate during the numerous mitotic divisions that are
completed in somatic cells as an individual ages and that these changes could lead to
diversity between two genetically identical individuals. Indeed, in their paradigm
shifting study, Fraga et al. (2005) found that patterns of epigenetic modifications in MZ
twin pairs do diverge as they become older. Martin (2005) described this phenomenon as
epigenetic drift. These alterations in an individual’s epigenetic profile appear to be much
more prevalent than DNA mutations (Bennett-Baker, 2003).
Since epigenetic mechanisms play a key role in establishing and maintaining
chromosomal structure, specifically heterochromatin and euchromatin, it is possible that
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epigenetic changes could be an underlying mechanism contributing to the acquisition of
structural and numerical chromosomal abnormalities associated with aging. For example,
methylation abnormalities have been linked to whole chromosome gains and losses in
colon cancer cells, linking aneuploidy to changes in methylation (Lengauer et al., 1997;
Reviewed by Richardson 2002). And more recently, hypomethylation of transposable
elements (LINE and Alu sequences) has been associated with increased genome
instability in non-small cell lung cancer (Daskalos et al., 2009).
Evidence that perturbations in methylation can result in increased frequencies of
chromosomal abnormalities in humans has also been obtained through studies of people
having immunodeficiency, centromeric region instability, facial anomalies (ICF)
syndrome, which is a rare autosomal recessive condition resulting from a mutation in the
methyltransferase gene (Kondo, et al. 2000). Individuals having ICF syndrome have an
increased frequency of structural chromosomal abnormalities, with aneuploidy also being
observed, albeit less frequently. Interestingly, the chromosomes of these patients show
accelerated telomere shortening and telomeric dysfunction. However, the most striking
observation regarding the preponderance of chromosomal abnormalities present in these
individuals is that they have a non-random chromosomal distribution, with anomalies
being seen most frequently for chromosomes 1 and 16, followed by chromosome 9,
which are all chromosomes having large heterochromatic regions (Gisselsson et al., 2005;
Ehrlich, et al., 2008).
To test the hypothesis that methylation alterations influence chromosomal
aneuploidy in humans, Guttenbach and Schmid (1994) and Fauth et al. (1998) treated
cells with the drug 5-azacytidine, which induces hypomethylation. Both groups observed
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an increased frequency of micronuclei containing the chromosomes 1, 9, and 16, which
led them to conclude that undermethylation of heterochromatin may be associated with
the loss of specific chromosomes. In our own studies of spontaneously acquired
chromosomal abnormalities in humans, we observed an increased frequency of losses for
chromosomes 1, 9, and 16 in lymphocytes and buccal mucosa cells (Rehder, et al., 2009).
One can speculate that the methylation status of these heterochromatic chromosomes may
play a role in their increased propensity for age-related losses. While there does seem to
be a consistent trend toward methylation differences playing a contributory role to the
acquisition of chromosomal abnormalities, it is unclear if these alleged differences arise
in response to environmental exposures.
One of the most straightforward means for detecting the presence of changes in
methylation in humans is through the study of identical twins, who have identical
genomic DNA. Assuming that monozygotic twins are born with the same methylation
profile, any variations in the methylation profile observed in adult identical co-twins are
thought to reflect acquired changes.
Thus, the primary aim of this small pilot study was to determine if acquired
methylation differences could be detected between monozygotic twins having low
compared to high micronuclei frequencies, as well as divergent environmental exposure
histories. We hypothesize that the co-twins having increased variation in their
micronuclei frequencies will also show more divergence in their methylation profiles.
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Materials and Methods

Sample
Two female monozygotic twin pairs were chosen from a larger ongoing study on the
basis of their frequency of micronuclei, as well as their environmental/lifestyle histories.
One pair (age 85) was very similar in environmental exposures, health history, and
micronuclei frequencies, while the other pair (69 years old) was very different for these
variables (Table 7). After providing their informed consent (VCU IRB protocol #179),
the participants submitted blood samples and a completed health history questionnaire.
Blood samples were collected by the participants’ health care providers. Following their
collection, the samples were shipped to our laboratory via an overnight delivery carrier.

DNA Isolation and Zygosity Determination
Genomic DNA was isolated from whole blood using the Puregene DNA Isolation
Kit (Qiagen). The zygosity status of the twins was confirmed using 13 highly
polymorphic short tandem repeat sequences (AmpFlSTR Profiler Plus and Cofiler kits
from Applied Biosystems, Foster City, CA) according to standard procedures.

MeDIP
A methylated DNA immunoprecipitation assay (MeDIP) was performed
according to the protocol of Mohn, et al. (2009) as shown in Figure 15. Briefly, genomic
DNA was isolated from whole blood using the Puregene DNA Isolation Kit (Qiagen). A
20µg aliquot of DNA was sonicated at 30% power for 10 seconds for a total of 4 cycles
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Table 7. Participant information for the methylation study.
Individual

Age

Pair

1
2
3
4

85
85
69
69

1
1
2
2

Micronuclei
High
Heart
observed/1000
blood
disease
binucleates
pressure
13
Yes
Yes
12
Yes
Yes
14
Yes
No
35
Yes
No
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Alcohol
usage

Tobacco
usage

No
No
No
No

No
No
No
Yes

Input DNA

M

M

Methylated
DNA

M
M
M
M

Sonication
M

Purification

M

M

Proteinase K
M

Ab 5mC
M

Ab

M

M

Ab

M

Ab

Ab

M

Dynabeads
M

M

Ab

M

Ab

Ab

Ab

Ab

Unmethylated
DNA

Figure 15. Illustration of Methylated DNA Immunoprecipitation (MeDIP)
procedure. Whole genomic DNA (black lines) isolated from whole blood was
sonicated. A 5-methylcytidine antibody was then added to the sonicated DNA,
with the antibody (Ab) being bound to the methylated DNA (M). A secondary
antibody (○), which was attached to magnetic beads (Dynabeads), was then
bound to the primary antibody. Using a magnetic rack, the methylated DNA was
separated from the unmethylated DNA. After a brief proteinase K digestion, the
methylated DNA was purified.
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(with 2 minutes “resting” intervals on ice between sonications), resulting in DNA
fragments that were between 300-1000 base pairs in length. After DNA purification, a 5methylcytidine mouse monoclonal antibody (Eurogentec) was added to the fragmented
DNA and incubated overnight at 4○C with continuous shaking. A secondary antibody,
Dynabeads M-280 sheep anti-mouse IgG (Invitrogen), was then added to the solution,
which was incubated for 2 additional hours at 4○C. The magnetic beads were then
collected using a magnetic rack (Invitrogen). After removal of the supernatant, the DNA
was washed three times in a 1x IP buffer solution (Mohn et al., 2009), and then digested
using proteinase K. The methylated DNA was then isolated by phenol:chloroform
extraction.

Array CGH
To optimize this assay for the recognition of differences between identical cotwins, two experimental approaches were performed, as shown in Figure 16. In the first
method, each individual’s methylated DNA was differentially labeled and cohybridized
to that same individual’s sonicated genomic, or “input” DNA. In the second
experimental approach, the methylated DNA fragments from the identical co-twins were
differentially labeled (one twin labeled with Cy3; one with Cy5) and then competitively
co-hybridized to the array chip. For both approaches, the array comparative genomic
hybridization (CGH) technique was performed according to the manufacturer guidelines
using a BAC array platform (over 5000 replicated BAC clones including 143 OMIM
genes at 100 Kb resolution, subtelomeres at 250 Kb, and screening of genomic backbone
at 565 Kb resolution.) (BlueGnome Ltd, Cambridge, UK).

75

Option 1
Twin 1

Twin 1

M

M

M

M

MeDIP

M

Co-Twin (Twin 2)

M

M

M

S. Input

MeDIP

Cy5

M

M

M

M

MeDIP

Cy3

Cy5

M

M

M

Twin 1

M

Cy3
M

Option 2

M
M

M

M
M

M

Array

M

Array

Figure 16. Illustration of the two different methods used for
array CGH. In experimental approach 1, the methylated DNA was
hybridized to that same individual’s sonicated genomic DNA (S.
Input). In experimental approach 2, the methylated DNA from twin
1 was hybridized to the methylated DNA of their identical co-twin
(twin 2).
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Array analysis
The arrays were scanned using a ScanArray Gx Plus scanner (Perkin Elmer). The
images were analyzed using a proprietary software program that was developed by
BlueGnome. Differences in methylated DNA amounts present were identified if the log2
ratio values exceeded 0.4 or were less than -0.4.

77

Results

Intra-individual MeDIP DNA hybridized to sonicated genomic DNA
The differential ratios of the methyl-enriched DNA compared to the sonicated
whole genomic DNA within the 4 individuals studied resulted in a range of 26 to 103
areas of divergence. Overall, hypermethylated regions (ranging from 17 to 89 per
individual) were detected more frequently than hypomethylated regions (ranging from 8
to 14). A comparison of the specific genomic information gained from these assays
showed 12 loci to be consistently altered in all of the 4 individuals, with an additional 11
regions showing either consistent hypo- or hypermethylation in 3 of the 4 individuals
(Table 8). While 17 of these common regions were consistently hypermethylated and 4
were consistently hypomethylated, 2 regions were differentially methylated
(hypermethylated in 2 individuals and hypomethylated in 2 individuals). Overall, the
methylation pattern in each individual was more similar to their co-twin’s pattern than
that of an unrelated individual (Table 9).
When comparing the co-twins’ patterns, a total of 24 differences were observed
between the co-twins of pair one, while a total of 22 differences were detected between
the co-twins of pair two (Table 9). However, the standard deviations of these
experiments, which were calculated by comparing the fluorochrome intensity values
present on the replicate [2 for non-coding regions and 3 for genes] BACs on the arrays,
were larger than those typically used for diagnostic interpretation, thereby underscoring
the need for replication of these results. A list of the differentially methylated BAC
clones and the genes involved are presented in Tables 10 and 11.
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Co-twin comparison using MeDIP DNA (twin 1) hybridized with MeDIP DNA (twin
2)
The direct competitive hybridization of the methyl-enriched co-twins’ DNA onto
the microarray resulted in the detection of no (zero) differences in patterns between the
co-twins of pair one. However, methylation differences were observed between the cotwins of pair two in 34 chromosome regions (Figure 17 and 18). Unlike the previous
method, the standard deviations for this experiment (0.05 and 0.1) were within the values
deemed acceptable for diagnostic use (0.1 or less). The genomic regions with differential
methylation for the identical co-twins from pair 2 (40 BACs) included 142 protein coding
genes, 10 processed transcripts, 3 RNA genes, and 14 pseudogenes (Table 12).
In this second experimental approach, one cannot clearly categorize the
methylation change that occurred as hypo- or hypermethylation since a gain in twin 1
could reflect a hypermethylation from the “normal” state in twin 2, or it could represent a
normal level, with twin 2 having hypomethylation.
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Table 8. Regions having consistent methylation changes (approach 1).
BAC

Characterization

Protein coding

RP11-58A11

Chromosomal
location
1p36.2

1MB backbone

RP5-1033K19

1p31.2

1MB backbone

RP11-290P14

1q44

1MB backbone

RP11-480A4

3p14.2

1MB backbone

RP11-16M12
RP11-374I17
RP11-565F4
RP11-420L4
RP11-417B10

3p12.3
3q26.31
5q23.1
5q35.1
7p11.1

1MB backbone*
1MB backbone
1MB backbone
1MB backbone
1MB backbone

RP4-669I17
RP11-19G1
RP13-438M3
RP11-357L5
RP11-125F14

7q36.1
9p23
10p11.21
10q22.1
11p11.2

1MB backbone
1MB backbone
1MB backbone
1MB backbone
Known disease
region

Processed
transcript

RNA gene

Pseudogene

PLEKHG5
NOL9
TAS1R1
ZBTB48
KLHL21
RPE65

AL591866.1

AL591866.2

EFCAB2
KIF26B
RP11-541C17.1

U1

AL139413.1
AL139413.2
AL589763.1
AC104164.2
AC104164.1
RP11-541C17.2

AC108752.1
NAALADL2

snoU13
AC119040.2

DOCK2
RP11-368M16.3
RP11-368M16.6
RP11-368M16.2
RP11-368M16.7
RP11-368M16.4
RP11-368M16.5
RP11-368M16.8
RP11-368M16.1
AC0648621.1
MLL3
PTPRD
CDH23
MADD
MYBPC3
SPI1
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Table 8 (continued). Regions having consistent methylation changes (approach 1).
BAC

Chromosomal
location

Characterization

RP11-176A16

11q14.1

1MB backbone

RP11-75L1

12p13.31

1MB backbone

RP11-125G9
RP11-420C17
RP11-449024

12p12.2
12q14.1
12q24.21

RP11-321F20
RP11-65B9
RP11-463D17
RP11-97N8

13q21.33
16p11.1
18q12.3
19p12

1MB backbone
1MB backbone
Known disease
region
1MB backbone
1MB backbone
1MB backbone*
1MB backbone

Protein coding

Processed
transcript
AC103881.1
AC062032.1

CLEC2D
CLECL1
CD69
KLRF1
CLEC2B
SLCO1C1

ZNF56
ZNF90
AC011477.4
AC007204.1
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RNA gene

Pseudogene

Table 9. Differential Methylation Patterns Observed following inter-individual
analysis
Individual
#
# Hypomethylated # Differences with
(age)
Hypermethylated
regions
co-twin pattern
regions
#73
73
7
2
#74

89

14

22

#C51

17

9

11

#C52

17

9

11
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Table 10. Regions having differential methylation between co-twin pair 1 as assessed from a comparison of patterns from
individual-based hybridizations (approach 1).
BAC

Characterization

RP11-24.23
RP11-145B4
RP11-117D22

Chromosomal
location
8q24.23
Xp21.2
1p32.3

Protein
coding

RP11-293B7
RP11-389K20
RP11-575H3

1q25.3
2p16.3
2p11.1

1MB backbone
1MB backbone
Proposed disease region

RGL1

RP11-554O1
RP11-120C2
RP11-45C13

3p14.3

1MB backbone

4q35.2

1MB backbone

RP11-323M9

5p15.33

Proposed disease region

CACNA2D3
DNAH12
MTNR1A
FAT1
AC010443.2
PLEKHG4B
AC021087.1
CCDC127
SDHA
PDCD6

RP11-494C5
RP11-132E3

5q33.2
8q22.3

1MB backbone
1MB backbone

RP11-328K22
RP11-349I16

10q22.3
11q21

1MB backbone
1MB backbone

1MB backbone
1MB backbone
1MB backbone

Processed
transcript

RNA gene

Pseudogene

AC119428.1
AC119428.2
AC139712.4
U6

GRIA1
RIMS2
AC107933.1
KCNMA1
AMOTL1
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Y_RNA

AL731575.1

AC0793041
AC018696.2
AC018696.7
AC018696.6
AC0186964
AC018696.1
AC018696.3
AC018696.5
AC116050.1
AC092057.1

Table 10 (continued). Regions having differential methylation between co-twin pair 1 as assessed from a comparison of
patterns from individual-based hybridizations (approach 1).
BAC

Characterization

RP11-320N7
RP11-480P7
RP11-38M15

Chromosomal
location
12p13.32
12q21.33
13q11

RP11-183G17
RP11-353B9

15q11.2
15q21.2

Proposed disease region
1MB Backbone

RP11-143C19

15q26.2

1MB backbone

RP11-342L3

16p13.3

Proposed disease region

Protein
coding

1MB backbone
1MB backbone
1MB backbone

Processed
transcript

RNA gene

Pseudogene
AC007207.1

RP1138M15.1

AL391382.6
AL391382.4

DTWD1
C15orf33
SPATA8
KCTD5
PRSS27
PRSS33
PRSS21
TCEB2
SRRM2
AC141586.1
AC141586.2
AC092117.3
AC092117.1
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AL391382.9
AL391382.5
AL391382.2
AL391382.12
AL391382.3
AL391382.1
AL391382.11
RP11-38M15.3
RP11-38M15.2

7SK
AC141586.3

SNORA3
AC092117.2

AC092117.4

Table 10 (continued). Regions having differential methylation between co-twin pair 1 as assessed from a comparison of
patterns from individual-based hybridizations (approach 1).
BAC

Characterization

RP11.394B2

Chromosomal
location
16q22.1

RP11-46H21

17p25.3

1MB backbone

RP3-324O17

20q11.21

1MB backbone

RP1-128O17
RP11-124N4

20q12
Xq23

1MB backbone
Known disease region

Protein
coding
IL34
MTSS1L
VAC14
AC020763.2
AC020763.1
ZNF750
B3GNTL1
AC068584.1
HM13
ID1

1MB backbone

DCX

85

Processed
transcript

RNA gene

Pseudogene

AL110115.3
AL110115.1

U6

AL110115.2

Table 11. Regions having differential methylation between co-twin pair 2 as assessed from a comparison of patterns from
individual-based hybridizations (approach 1).
BAC

Characterization

Protein coding

RP11-480A4

Chromosomal
location
3p14.2

1MB backbone

RP11-641C17.1

RP11-239O20
RP11-191M7
RP11-349C2

4q31.22
5q33.1
8q24.3

1MB backbone
1MB backbone
1MB backbone

SLC10A7

RP13-438M3
RP11-125F14

10p11.21
11p11.2

1MB backbone
1MB backbone

RP11-321F20
RP11-45G12
RP13-60P5

13q21.33
17p11.2
Xp21.3

1MB backbone
1MB backbone
1MB backbone

RP5-914P14
RP11-549H3

Xq23

Known disease
region

ADCK5
CPSF1
AF205589.2
VPS28
CYHR1
NFKBIL2
KIFC2
FOXH1
LRRC24
LRRC14
PPP1R16A
C8orf82
GPT
MFSD3
RECQL4
AC084125.1

Processed
transcript

RNA gene

Pseudogene
AC104164.2
AC104164.1
RP11-641C17.2

AC084125.2

has-mir-939
has-mir-1234

MADD
MYBPC3
SPI1

MAGEB18
PAK3
CAPN6
DCX
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U6

RP13-60P5.1
MAGEB6B
AL031117.1

Table 11 (continued). Regions having differential methylation between co-twin pair 2 as assessed from a comparison of
patterns from individual-based hybridizations (approach 1).
BAC

Characterization

Protein coding

RP11-58A11

Chromosomal
location
1p36.31

1MB backbone

RP11-290P14

1q44

1MB backbone

RP11-387A1

2q31.1

Known disease
region

RP11-374I17

3q26.31

PLEKHG5
NOL9
TAS1R1
ZBTB48
KLHL21
EFCAB2
KIF26B
EVX2
HOXD13
HOXD12
HOXD10
HOXD11
HOXD9
HOXD3
HOXD8
HOXD4
HOXD1
AC009336.1
NAALADL2

RP11-565F4
RP11-140L4

5q23.1
11p15.4

RP11-179A16
RP11-75L1

11q14.1
12p13.31

Proposed disease
region
1MB backbone
1MB backbone

RP11-420C17

12q14.1

1MB backbone

PRR16
MRGPRG
MRGPRE
CLEC2D
CLECL1
CD69
KLRF1
CLEC2B
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Processed
transcript

AC009336.5
AC009336.4
AC009336.2

RNA gene

Pseudogene

AL591866.1

AL591866.2

U1

AL589763.1

has-mir-10b

snoU13
AC119040.2
U4
AC109309.1
C11orf36

AC109309.2
AC109309.3

Table 11 (continued). Regions having differential methylation between co-twin pair 2 as assessed from a comparison of
patterns from individual-based hybridizations (approach 1).
BAC

Characterization

Protein coding

RP11-38M15

Chromosomal
location
13q11

1MB backbone

RP11-38M15.1

RP11-183G17

15q11.2

Proposed disease
region

88

Processed
transcript
AL391382.6
AL391382.4

RNA gene

Pseudogene

U6
AL391382.8

AL391382.9
AL391382.5
AL391382.2
AL391382.12
AL391382.3
AL391382.1
AL391382.11
RP11-38M15.3

Poppy

Figure 17. Whole genomic view from software analysis of MeDIP product from twin 1
hybridized to the MeDIP product from twin 2 (pair 1) No (zero) differences were observed for
the pattern of methylated DNA present in these identical co-twins (s.d.= 0.05).
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Hi

Figure 18. Whole genomic view from software analysis of MeDIP product from twin 3 hybridized to the MeDIP
product from twin 4 (pair 2). A total of 33 differences in DNA methylation patterns were observed between these
identical co-twins, who were discordant for high/low frequencies of micronuclei. These differences are depicted as red or
green lines parallel to the ideogram at the chromosomal location of the divergent DNA (s.d.= 0.1).
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Table 12. Regions having differential methylation between co-twin pair 2 as assessed from the competitive hybridization
experimental approach (approach 2).
BAC

Chromosomal
location
1p36.33

Characterization

Protein coding

Known disease region

PRKCZ
C1orf86
AL590822.1
AL590822.3
SKI
ATAD3B
ATAD3A
C1orf70
SSU72
AL645728.1

RP11-9O10
RP11-118M12

2p12
2q37.3

1MB backbone
1MB backbone

RP11-124522
RP11-180A12
RP11-43F13

4p16.3
4p16.1
5p15.33

1MB backbone
1MB backbone
Known disease region

RP11-138M1

5q13.2

RP4-800G7
RP4-669I17

7q36.1

Known polymorphic
region
1MB backbone

RP11-181G12
RP5-832C2

Processed
transcript
RP11-181G12.1
AL590822.2
AL590822.4

RNA gene

Pseudogene
AL645728.3

AQP12B
AC011298.2
AC011298.3
AC011298.1
AQP12A
KIF1A
AC105916.1
AC116351.2
NKD2
SLC12A7
AC116351.1
AC116351.5
AC140134.2
AC138866.1
MLL3
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AC1163513

AC1163514

Table 12 (continued). Regions having differential methylation between co-twin pair 2 as assessed from the competitive
hybridization experimental approach (approach 2).
BAC

Chromosomal
location
8p23.3

Characterization

Protein coding

High GC content region

RP11-417A4

9q34.3

1MB backbone

RP13-244L6

10q11.21

Known disease region

RP11-357L5
RP13-449N13
RP11-2B17
RP11-58D3

10q22.1
10q26.3
11p15.5
11p13.1

1MB backbone
1MB backbone
1MB backbone
1MB backbone

AC105233.6
FAM90A11
AC105233.4
AC105233.2
AC105233.3
AC105233.5
FAM90A24P
PNPLA7
MRPL41
WDR85
ZMYND19
ARRDC1
C9orf37
EHMT1
CSGALNACT2
RASGEF1A
CDH23
STK32C

RP11-119D9

11q13.2

Known disease region

RP11-248K13
RP11-52B19

KAT5
RNASEH2C
OVOL1
SNX32
CFL1
MUS81
AP003716.2
AP003716.1
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Processed
transcript

RNA gene

Pseudogene

hsa-mir548i-3

AC105233.1

AL590627.1

AC068707.3

AP001266.2
AP001266.2

Table 12 (continued). Regions having differential methylation between co-twin pair 2 as assessed from the competitive
hybridization experimental approach (approach 2).
BAC

Characterization

Protein coding

RP11-567M21

Chromosomal
location
11q24.3

1MB backbone

RP11-429N9

12p21.32

1MB backbone

PRDM10
NCRNA00167
AP003041.3
APLP2
C12orf50
C12orf9
CEP290

RP11-449O24
RP11-503G7

12q24.21
12q24.33

Known disease region
1MB backbone

RP3-514A23

14q24.2

1MB backbone

RP11-358F6

16p13.3

High GC content region

RP11-288I13
RP11-278A23

16p12.3
16q24.2

1MB backbone
1MB backbone

AC148477.3
MUC8
FBRSL1
RGS6
DPF3
SOX8
SSTR5
C1QTNF8
AC009041.3
AC009041.7
AC009041.1
AC009041.6
AC009041.8
AC009041.4
AC009041.5
AL031713.1
XYLT1
JPH3
KLHDC4
AC010536.1
AC010536.2

93

Processed
transcript

RNA gene

Pseudogene

U4

AP003041.4
AP003041.1

AC090060.1

AC009041.2

Table 12 (continued). Regions having differential methylation between co-twin pair 2 as assessed from the competitive
hybridization experimental approach (approach 2).
BAC

Chromosomal
location
16q24.3

Characterization

Protein coding

1MB backbone

RP11-475F12
RP11-45506

17q25.3

Proposed disease region

RP11-100K18
RP11-315M18
RP11-330I7

18q23

1MB backbone

CPNE7
DPEP1
CHMP1A
C16orf55
CDK10
SPATA2L
C16orf7
ZNF276
AC010538.1
SPIRE2
TCF25
TUBB3
DEF8
GAS8
DBNDD1
AC092143.1
AC092143.3
C16orf3
AC133919.7
FASN
CCDC57
SLC16A3
CSNK1D
AC132872.4
AC068473.1

19p13.3

1MB backbone

RP11-368I7
RP11-533D19

CD70
C3
TNFSF14
TRIP10
GPR108
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Processed
transcript
AFG3L1

RNA gene

Pseudogene

AC132872.2

AC008760.1

Table 12 (continued). Regions having differential methylation between co-twin pair 2 as assessed from the competitive
hybridization experimental approach (approach 2).
BAC

Characterization

Protein coding

RP11-9B17

Chromosomal
location
19p13.2

1MB backbone

RP11-353C18

20q11.22

1MB backbone

RP11-93B14

20q13.33

Proposed disease region

ZNF781
ZNF607
ZNF573
AC093227.1
NFS1
ROMO1
RBM39
AL357374.3
PHF20
RP11-93B14.1
SLCO4A1
C20orf90
NTSR1

RP11-135B17

21q22.3

1MB backbone

RP5-1119A7

22q12.3

1MB backbone

RP11-164E23

22q13.33

Known disease region

DIP2A
S100B
PRMT2
TXN2
FOXRED2
EIF3D
RP5-1119A7.1
CACNG2
SAPS2
SBF1
ADM2
MIOX
LMF2
NCAPH2
SCO2
TYMP
ODF3B
KLHDC7B
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Processed
transcript

RNA gene

Pseudogene

BXDC1P

RP11-93B14.2
AL357033.1

AP000339.1

CR383704.1
AL022313.1

U62317.1

Discussion

To achieve the primary goal of this study, the methylation profiles of 2
monozygotic twin pairs were compared using two different experimental approaches.
For this preliminary assessment, these particular twin pairs were selected on the basis of:
(1) their age (we selected older twins since it has been hypothesized that methylation
changes accumulate with age); and (2) micronuclei frequencies (the co-twins from one
pair had very similar micronuclei frequencies, while the co-twins from the other pair
presented with significantly different micronuclei frequencies).
Each of the two whole genome experimental approaches used in this pilot study
had apparent strengths and weaknesses. A strength of the first technique (Approach 1)
was that it enabled one to directly assess if the observed changes in patterns resulted from
hypermethylation or hypomethylation. Of interest was the observation of 23 consistent
regions, for methylation, that were present between the study participants. Some common
areas are expected since the sample DNA was isolated from the same tissue type (white
blood cells). Interestingly, the standard deviations associated with these experiments
exceeded those typically obtained from conventional genomic hybridization experiments.
The cause for this increase is not clear, with additional experiments being required to
discern if this finding reflects a consistent problem associated with the methodological
approach. Despite the increased standard deviation values seen (which makes the
detection of differences more difficult), variation in the identified regions was detected
between the identical co-twins. However, the total number of differences between pairs
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was very similar, with slightly more divergence being observed for the pair having the
least difference in micronuclei frequencies and exposures.
In the second technique (approach 2), the methyl-enriched DNA from the
identical co-twins were directly compared. As noted in the results, a shortcoming of this
experimental approach is that one cannot directly classify the recognized alterations as
being attributable to hyper- versus hypo-methylation, since the observed values are in
relation to those seen in the methyl enriched portion of the co-twin’s DNA rather than to
the overall genome. However, a benefit of this method is that it is more cost effective
(reduces cost by half ) and may be more sensitive for detecting differences between cotwins, since it led to the recognition of 33 differences between the co-twins of pair 2 [but
fewer (zero) differences in the co-twins of pair one]. Also, since the methyl-enriched
DNAs that are co-hybridized in these experiments were collected using identical
procedures, the standard deviations of this experiment were lower, falling within the
clinically acceptable range.
When comparing the types of regions identified using each of the two techniques,
it appears that approach 1 identified more RNA genes and pseudogenes, while approach 2
identified more protein coding regions. The biological relevance of this observation is
unclear and warrants further evaluation using a second confirmatory approach (such as
bisulfite sequencing methodology).
In summary, while the sample size used for this pilot study was small, the results
support the hypothesis that changes in the global methylation profiles were present
between these identical twins, who were 69 and 85 years old. Excitingly, based on
approach two, these changes appear to be more prevalent in people having more diversity
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for environmental/health histories, as well as biomarker (micronuclei) divergence. Our
future studies, in which we will study epigenome patterns between identical co-twins
ranging in age from 7 to 85, should enable us to determine at what age monozygotic
twins begin to diverge epigenetically, if specific environmental exposures influence this
divergence, and if this phenomenon can be consistently correlated with genetic indicators
of aging, such as aneuploidy or micronuclei frequencies.
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Chapter 6.

Conclusions

A. To determine the influence that genetic and/or environmental factors have on the
frequency of spontaneously occurring micronuclei in children and adults, cells from
identical and fraternal twins were evaluated. These studies led to the following primary
conclusions:

1. No significant difference in micronuclei frequencies was seen for males (1.39% ±
0.11%) compared to females (1.22% ± 0.10%) (p=0.87).

2. Micronuclei frequencies significantly increased with age (p<0.0001, r=0.446), ranging
from a low of 0.56%  0.11% in 7-9 year-olds, to a high of 2.25%  0.25% in 60-69
year-olds.

3. Although monozygotic twins (r=0.5, p=0.003) had a higher correlation coefficient than
dizygotic twins (r=0.42, p=0.118), these values indicated a contribution of environmental
factors. Model fitting, implemented in Mx, showed the best fit for the data to result from
contributions due to either additive genetic and unique environment or common and
unique environmental factors.
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4. Environmental exposures and health conditions that showed a significantly increased
frequency of micronuclei included a history of allergies (p=0.00019), and consumption of
vitamin E supplements (p=0.0251). In contrast, significantly lower micronuclei
frequencies were associated with eating fruit (p=0.0162), eating leafy green vegetables
(p= 0.0007), having a history of arthritis (p=0.0005), and having a history of heart disease
(p=0.0381). However, this latter effect may be confounded by medication usage since
ACE inhibitors and diuretics were associated with significantly decreased (p=0.0132) or
increased (p=0.0023) micronuclei frequencies, respectively.

B. For a subset of twins having 5% or more micronuclei containing sex chromosomes,
the number of sex chromosomes (and chromosome 17) present in the binucleates having
one or more micronuclei was determined. These studies led to the following primary
conclusions:

1. In both genders, the frequency of micronuclei containing a sex chromosome was
significantly higher than that observed for chromosome 17 (autosomal control).

2. The probe signal patterns noted in the total of 1,017 binucleated cells having at least
one micronucleus with a signal for chromosomes X, Y, or 17 included three primary
types of binucleate cells: those having a hyperdiploid complement; a hypodiploid
complement; or a euploid complement, the latter of which had an apparent chromosomal
imbalance that was “corrected” through its exclusion into the micronucleus (trisomy
rescue).
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3. In the males, the percentage of cells having a euploid binucleate with a “corrected”
micronuclear pattern for the Y chromosome was significantly higher in the younger
subjects (p=0.026), while those having a hypodiploid binucleate pattern tended to
increase with age.

4. In the females, the percentage of cells having a euploid binucleate with a “corrected”
micronuclear pattern for the X chromosome was significantly higher in the younger
subjects (p=0.030), while those having a hypodiploid binucleate pattern tended to
increase with age.

5. No significant age-related difference in the proportion of hyperdiploid binucleates was
observed for the X (males or females) or Y chromosome (males).

C. The chromosomal contents of micronuclei were determined using Spectral
Karyotyping (SKY) methodology. These age-related influences on chromosome-specific
frequencies of micronuclei were also evaluated. These studies led to the following
primary conclusions:

1. The majority of micronuclei (89.6%) contained chromatin from a single chromosome.
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2. All 24 chromosomes were observed to be present in at least 5 micronuclei. However,
the chromosome-specific frequencies varied, with the sex chromosomes being observed
most frequently in the micronuclei evaluated from both males and females (p<0.0001).

3. Of the autosomes, chromosomes 4, 8, and 9 were found with a significantly higher
frequency than expected by chance, while chromosomes 17 and 22 were found much less
frequently than expected (p<0.0001).

4. No difference was observed in the pattern of autosomes present in the micronuclei
studied from males compared to females (p=0.7).

5. There was no significant difference in the pattern of autosomal chromatin exclusion
into micronuclei between adults (ages 25-81) and children (ages 7-19 years) (p=0.9).

6. A positive correlation was detected for the proportion of X chromatin-containing
micronuclei in females with age (p<0.0001) and for the Y chromosome in males with age
(p<0.0001).

7. The ability of the SKY software to accurately detect the chromosomal contents of a
micronucleus was determined to be between 83% (when using centromeric probes) and
89% (when using painting probes). The discrepancy in this value suggests that some of
the micronuclei may contain chromosomal fragments.
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D. Global methylation profiles were determined (using a MeDIP Chip) for two
monozygotic twin pairs by isolating methyl-enriched DNA and hybridizing it to either the
co-twins methyl-enriched DNA or to the individual’s sonicated total DNA (methylated
and non-methylated). These studies led to the following primary conclusions:

1. Overall, hypermethylated regions (ranging from 17 to 89 per individual) were detected
more frequently than hypomethylated regions (ranging from 8 to 14).

2. A comparison of the specific genomic information gained from hybridizing an
individual’s methyl-enriched DNA to their sonicated total DNA showed 12 loci to be
consistently altered in all of the 4 individuals, with an additional 11 regions showing
either consistent hypo- or hypermethylation in 3 of the 4 individuals.

3. Through direct competitive hybridization of the co-twins’ methyl-enriched DNA onto
a genome-wide microarray, an increased frequency of methylation differences was
observed between the co-twins having different micronuclei frequencies and
environmental exposures (33 differences) when compared to the divergence observed
between the co-twin’s having similar micronuclei frequencies and environmental
exposures (0 methylation differences). This finding suggests there may be a link between
acquired chromosomal instability and epigenetic changes.

In summary, genetic and epigenetic changes, as assessed through micronuclei and
methylation, do occur with age and these acquired abnormalities appear to be complex
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traits that are influenced by unique environmental factors as well as other factors (such as
additive genetic or common environmental effects). We are the first to have discovered
an in vivo link between blood pressure medications and micronuclei frequencies. We
have also performed the most comprehensive study to date examining the chromosomal
contents of micronuclei. In addition, we are the first to propose the possible “corrective”
function of micronuclei. It is anticipated that the baseline micronuclei data we presented
in this study will help future researchers develop preventative care, screening tests, and
therapies for the various health conditions associated with micronuclei.
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